Literaturverzeichnis

1 Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology. 2001 Dec;121(6):1329-38. doi: 10.1053/gast.2001.29572. PMID: 11729112.

2 Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007 Jul;5(7):844-50; quiz 769. doi: 10.1016/j.cgh.2007.03.021. Epub 2007 Jun 5. PMID: 17553753.

3 Koumbi L, Giouleme O, Vassilopoulou E. Non-Celiac Gluten Sensitivity and Irritable Bowel Disease: Looking for the Culprits. Curr Dev Nutr. 2020 Dec 31;4(12):nzaa176. doi: 10.1093/cdn/nzaa176. PMID: 33442571; PMCID: PMC7788486.

4 Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, Burton D, Zinsmeister AR. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013 May;144(5):903-911.e3. doi: 10.1053/j.gastro.2013.01.049. Epub 2013 Jan 25. PMID: 23357715; PMCID: PMC3633663.

5 Losurdo G, Principi M, Iannone A, Amoruso A, Ierardi E, Di Leo A, Barone M. Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm. World J Gastroenterol. 2018 Apr 14;24(14):1521-1530. doi: 10.3748/wjg.v24.i14.1521. PMID: 29662290; PMCID: PMC5897856.

6 Nilholm C, Roth B, Ohlsson B. A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients. Nutrients. 2019 Jul 20;11(7):1662. doi: 10.3390/nu11071662. PMID: 31330810; PMCID: PMC6682926.

7 Peterson ML, Herber R. Intestinal sucrase deficiency. Trans Assoc Am Physicians. 1967;80:275-83. PMID: 6082247.

8 Garcia-Etxebarria K, Zheng T, Bonfiglio F, Bujanda L, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B, Simren M, Walter S, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Jonkers D, Eswaran S, Chey WD, Kashyap P, Chang L, Mayer EA, Wouters MM, Boeckxstaens G, Camilleri M, Franke A, D'Amato M. Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients. Clin Gastroenterol Hepatol. 2018 Oct;16(10):1673-1676. doi: 10.1016/j.cgh.2018.01.047. Epub 2018 Feb 21. PMID: 29408290; PMCID: PMC6103908.

9 Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Front Psychiatry. 2020 Jul 10;11:664. doi: 10.3389/fpsyt.2020.00664. PMID: 32754068; PMCID: PMC7366247.

10 Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000 Dec;95(12):3503-6. doi: 10.1111/j.1572-0241.2000.03368.x. PMID: 11151884.

11 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017 Mar 15;11(2):196-208. doi: 10.5009/gnl16126. PMID: 28274108; PMCID: PMC5347643.

 

12 Ghoshal UC, Srivastava D, Misra A, Ghoshal U. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2016 Mar;28(3):281-9. doi: 10.1097/MEG.0000000000000557. PMID: 26731696.

 

1 Lacy BE, Rosemore J, Robertson D, Corbin DA, Grau M, Crowell MD. Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome. Scand J Gastroenterol. 2006 Aug;41(8):892-902. doi: 10.1080/00365520600554451. PMID: 16803687.

2 Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Jonsson JS, Bjornsson E, Thjodleifsson B. Irritable bowel syndrome: physicians' awareness and patients' experience. World J Gastroenterol. 2012 Jul 28;18(28):3715-20. doi: 10.3748/wjg.v18.i28.3715. PMID: 22851864; PMCID: PMC3406424.

3 Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017 Oct 26;6(11):99. doi: 10.3390/jcm6110099. PMID: 29072609; PMCID: PMC5704116.

4 Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014 Jun 14;20(22):6759-73. doi: 10.3748/wjg.v20.i22.6759. PMID: 24944467; PMCID: PMC4051916.

5 Zimmerman J. Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms. Dig Dis Sci. 2003 Apr;48(4):743-9. doi: 10.1023/a:1022840910283. PMID: 12741465.

6 Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002 Apr;122(4):1140-56. doi: 10.1053/gast.2002.32392. PMID: 11910364.

7 Icks A, Haastert B, Enck P, Rathmann W, Giani G. Prevalence of functional bowel disorders and related health care seeking: a population-based study. Z Gastroenterol. 2002 Mar;40(3):177-83. doi: 10.1055/s-2002-22324. PMID: 11901451.

8 Gulewitsch MD, Enck P, Hautzinger M, Schlarb AA. Irritable bowel syndrome symptoms among German students: prevalence, characteristics, and associations to somatic complaints, sleep, quality of life, and childhood abdominal pain. Eur J Gastroenterol Hepatol. 2011 Apr;23(4):311-6. doi: 10.1097/MEG.0b013e3283457b1e. PMID: 21399505.

9 Kim YS, Kim N. Sex-Gender Differences in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018 Oct 1;24(4):544-558. doi: 10.5056/jnm18082. PMID: 30347934; PMCID: PMC6175559.

10 Pretorius L, Van Staden ADP, Van der Merwe JJ, Henning N, Smith C. Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome. Inflammopharmacology. 2022 Feb;30(1):267-281. doi: 10.1007/s10787-021-00906-8. Epub 2022 Jan 13. PMID: 35022916.

11 Toner BB. Cognitive-behavioral treatment of irritable bowel syndrome. CNS Spectr. 2005 Nov;10(11):883-90. doi: 10.1017/s1092852900019854. PMID: 16273018.

12 Creed F. Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies. Aliment Pharmacol Ther. 2019 Sep;50(5):507-516. doi: 10.1111/apt.15396. Epub 2019 Jul 17. PMID: 31313850.

13 Mönnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol. 2011 Aug;45 Suppl:S98-101. doi: 10.1097/MCG.0b013e31821fbf44. PMID: 21666428.

14 Taft TH, Bedell A, Naftaly J, Keefer L. Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort. Neurogastroenterol Motil. 2017 Feb;29(2):10.1111/nmo.12921. doi: 10.1111/nmo.12921. Epub 2016 Aug 8. PMID: 27501483; PMCID: PMC5276799.

15 Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001 May;96(5):1340-9. doi: 10.1111/j.1572-0241.2001.03789.x. PMID: 11374666.

16 Drossman DA, Morris CB, Schneck S, Hu YJ, Norton NJ, Norton WF, Weinland SR, Dalton C, Leserman J, Bangdiwala SI. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009 Jul;43(6):541-50. doi: 10.1097/MCG.0b013e318189a7f9. PMID: 19384249; PMCID: PMC2700202.

17 Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004 Dec;2(12):1064-8. doi: 10.1016/s1542-3565(04)00545-2. PMID: 15625650.

18 Wilson TS. PAIN IN MUCOUS COLITIS AND IN IRRITABLE STATES OF THE COLON IN GENERAL. Br Med J. 1909 Jul 10;2(2532):73-7. doi: 10.1136/bmj.2.2532.73. PMID: 20764577; PMCID: PMC2320222.

19 Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy KT, Banka NH, Bose K, Bohidar NP, Chakravartty K, Shekhar NC, Desai N, Dutta U, Das G, Dutta S, Dixit VK, Goswami BD, Jain RK, Jain S, Jayanthi V, Kochhar R, Kumar A, Makharia G, Mukewar SV, Mohan Prasad VG, Mohanty A, Mohan AT, Sathyaprakash BS, Prabhakar B, Philip M, Veerraju EP, Ray G, Rai RR, Seth AK, Sachdeva A, Singh SP, Sood A, Thomas V, Tiwari S, Tandan M, Upadhyay R, Vij JC. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008 Jan-Feb;27(1):22-8. PMID: 18541934.

20 Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):56-66. doi: 10.1038/s41575-020-00360-x. Epub 2020 Oct 8. PMID: 33033392; PMCID: PMC7542092.

21 Jackson LS. Chemical food safety issues in the United States: past, present, and future. J Agric Food Chem. 2009 Sep 23;57(18):8161-70. doi: 10.1021/jf900628u. PMID: 19719131.

22 Rinninella E, Cintoni M, Raoul P, Gasbarrini A, Mele MC. Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track. Int J Environ Res Public Health. 2020 Nov 27;17(23):8816. doi: 10.3390/ijerph17238816. PMID: 33260947; PMCID: PMC7730902.

23 Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. doi: 10.1016/S2468-1253(20)30217-X. Epub 2020 Jul 20. Erratum in: Lancet Gastroenterol Hepatol. 2020 Dec;5(12):e8. PMID: 32702295.

24 Corsetti M, Whorwell P. The global impact of IBS: time to think about IBS-specific models of care? Therap Adv Gastroenterol. 2017 Sep;10(9):727-736. doi: 10.1177/1756283X17718677. Epub 2017 Jul 31. PMID: 28932273; PMCID: PMC5598808.

25 Buscail C, Sabate JM, Bouchoucha M, Kesse-Guyot E, Hercberg S, Benamouzig R, Julia C. Western Dietary Pattern Is Associated with Irritable Bowel Syndrome in the French NutriNet Cohort. Nutrients. 2017 Sep 7;9(9):986. doi: 10.3390/nu9090986. PMID: 28880222; PMCID: PMC5622746.

26 Guo YB, Zhuang KM, Kuang L, Zhan Q, Wang XF, Liu SD. Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut Liver. 2015 Sep 23;9(5):649-56. doi: 10.5009/gnl13437. PMID: 25266811; PMCID: PMC4562783.

27 Gwee KA. Irritable bowel syndrome in developing countries--a disorder of civilization or colonization? Neurogastroenterol Motil. 2005 Jun;17(3):317-24. doi: 10.1111/j.1365-2982.2005.00627.x. PMID: 15916618.

28 Waxman D. The irritable bowel: a pathological or a psychological syndrome? J R Soc Med. 1988 Dec;81(12):718-20. doi: 10.1177/014107688808101212. PMID: 3065500; PMCID: PMC1291885.

29 Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011 Apr;17(2):131-9. doi: 10.5056/jnm.2011.17.2.131. Epub 2011 Apr 27. PMID: 21602989; PMCID: PMC3093004.

30 Bradley S, Alderson S, Ford AC, Foy R. General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study. Fam Pract. 2018 Jan 16;35(1):74-79. doi: 10.1093/fampra/cmx053. PMID: 28985313.

31 Dapoigny M, Stockbrügger RW, Azpiroz F, Collins S, Coremans G, Müller-Lissner S, Oberndorff A, Pace F, Smout A, Vatn M, Whorwell P. Role of alimentation in irritable bowel syndrome. Digestion. 2003;67(4):225-33. doi: 10.1159/000072061. PMID: 12966230.

32 Spiller R. Impact of Diet on Symptoms of the Irritable Bowel Syndrome. Nutrients. 2021 Feb 9;13(2):575. doi: 10.3390/nu13020575. PMID: 33572262; PMCID: PMC7915127.

33 Borghini R, Donato G, Alvaro D, Picarelli A. New insights in IBS-like disorders: Pandora's box has been opened; a review. Gastroenterol Hepatol Bed Bench. 2017 Spring;10(2):79-89. PMID: 28702130; PMCID: PMC5495893.

34 Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2015 Jul;42(1):3-11. doi: 10.1111/apt.13227. Epub 2015 Apr 27. PMID: 25913530.

35 Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, Morley S, Sanders DS. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol. 2010 May;8(5):433-8. doi: 10.1016/j.cgh.2009.09.032. Epub 2009 Oct 14. PMID: 19835990.

36 Poon D, Law GR, Major G, Andreyev HJN. A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome. Sci Rep. 2022 Feb 4;12(1):1949. doi: 10.1038/s41598-022-05933-1. PMID: 35121775; PMCID: PMC8817019.

37 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019 Jun 10;10:1136. doi: 10.3389/fmicb.2019.01136. Erratum in: Front Microbiol. 2019 Aug 13;10:1870. PMID: 31244784; PMCID: PMC6579922.

38 Davenport ER, Sanders JG, Song SJ, Amato KR, Clark AG, Knight R. The human microbiome in evolution. BMC Biol. 2017 Dec 27;15(1):127. doi: 10.1186/s12915-017-0454-7. PMID: 29282061; PMCID: PMC5744394.

39 Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Med. 2011 Mar 4;3(3):14. doi: 10.1186/gm228. PMID: 21392406; PMCID: PMC3092099.

40 Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018 Dec 19;10(472):eaap8914. doi: 10.1126/scitranslmed.aap8914. PMID: 30567928.

41 Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012 Aug;4(8):1095-119. doi: 10.3390/nu4081095. Epub 2012 Aug 21. Erratum in: Nutrients. 2012 Oct;4(11)1552-3. PMID: 23016134; PMCID: PMC3448089.

42 Aguilera M, Cerdà-Cuéllar M, Martínez V. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes. 2015;6(1):10-23. doi: 10.4161/19490976.2014.990790. Epub 2015 Jan 20. PMID: 25531553; PMCID: PMC4615720.

43 Sadeghi A, Biglari M, Nasseri Moghaddam S. Post-infectious Irritable Bowel Syndrome: A Narrative Review. Middle East J Dig Dis. 2019 Apr;11(2):69-75. doi: 10.15171/mejdd.2019.130. Epub 2019 Mar 25. PMID: 31380002; PMCID: PMC6663289.

44 Dai C, Jiang M. The incidence and risk factors of post-infectious irritable bowel syndrome: a meta-analysis. Hepatogastroenterology. 2012 Jan-Feb;59(113):67-72. doi: 10.5754/hge10796. PMID: 22024145.

45 Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov;3(11):1057-65. doi: 10.1016/s1542-3565(05)00184-9. PMID: 16271334.

46 Villani AC, Lemire M, Thabane M, Belisle A, Geneau G, Garg AX, Clark WF, Moayyedi P, Collins SM, Franchimont D, Marshall JK. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology. 2010 Apr;138(4):1502-13. doi: 10.1053/j.gastro.2009.12.049. Epub 2010 Jan 4. PMID: 20044998.

47 El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020 May;69(5):859-867. doi: 10.1136/gutjnl-2019-319630. Epub 2019 Dec 18. PMID: 31852769; PMCID: PMC7229896.

48 Al-Khatib K, Lin HC. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver. 2009 Mar;3(1):14-9. doi: 10.5009/gnl.2009.3.1.14. Epub 2009 Mar 31. PMID: 20479895; PMCID: PMC2871556.

49 Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep. 2011 Aug;13(4):323-30. doi: 10.1007/s11894-011-0197-5. PMID: 21552990.

50 Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):71-8. doi: 10.1111/j.1440-1746.2005.04143.x. PMID: 16706815.

51 Ng QX, Soh AYS, Loke W, Lim DY, Yeo WS. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018 Sep 21;11:345-349. doi: 10.2147/JIR.S174982. PMID: 30288077; PMCID: PMC6159811.

52 Aguilera-Lizarraga J, Florens MV, Viola MF, Jain P, Decraecker L, Appeltans I, Cuende-Estevez M, Fabre N, Van Beek K, Perna E, Balemans D, Stakenborg N, Theofanous S, Bosmans G, Mondelaers SU, Matteoli G, Ibiza Martínez S, Lopez-Lopez C, Jaramillo-Polanco J, Talavera K, Alpizar YA, Feyerabend TB, Rodewald HR, Farre R, Redegeld FA, Si J, Raes J, Breynaert C, Schrijvers R, Bosteels C, Lambrecht BN, Boyd SD, Hoh RA, Cabooter D, Nelis M, Augustijns P, Hendrix S, Strid J, Bisschops R, Reed DE, Vanner SJ, Denadai-Souza A, Wouters MM, Boeckxstaens GE. Local immune response to food antigens drives meal-induced abdominal pain. Nature. 2021 Feb;590(7844):151-156. doi: 10.1038/s41586-020-03118-2. Epub 2021 Jan 13. PMID: 33442055; PMCID: PMC7610810.

53 Aguilera-Lizarraga J, Florens M, Hussein H, Boeckxstaens G. Local immune response as novel disease mechanism underlying abdominal pain in patients with irritable bowel syndrome. Acta Clin Belg. 2021 Oct 28:1-8. doi: 10.1080/17843286.2021.1996069. Epub ahead of print. PMID: 34709996.

54 Philpott H, Gibson P, Thien F. Irritable bowel syndrome – An inflammatory disease involving mast cells. Asia Pac Allergy. 2011 Apr;1(1):36-42. doi: 10.5415/apallergy.2011.1.1.36. Epub 2011 Apr 26. PMID: 22053295; PMCID: PMC3206231.

55 Spiller R, Major G. IBS and IBD – separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016 Sep 26;13(10):613-21. doi: 10.1038/nrgastro.2016.141. PMID: 27667579.

56 Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jul;19(7):545-52. doi: 10.1111/j.1365-2982.2007.00925.x. PMID: 17593135.

57 Hanning N, Edwinson AL, Ceuleers H, Peters SA, De Man JG, Hassett LC, De Winter BY, Grover M. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol. 2021 Feb 24;14:1756284821993586. doi: 10.1177/1756284821993586. PMID: 33717210; PMCID: PMC7925957.

58 Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis. 2016 Oct;1(3):135-145. doi: 10.1159/000447252. Epub 2016 Jul 20. PMID: 29922669; PMCID: PMC5988153.

59 Wang YH. Developing food allergy: a potential immunologic pathway linking skin barrier to gut. F1000Res. 2016 Nov 10;5:F1000 Faculty Rev-2660. doi: 10.12688/f1000research.9497.1. PMID: 27853507; PMCID: PMC5105878.

60 Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004 Apr;141(8):1285-93. doi: 10.1038/sj.bjp.0705762. PMID: 15100164; PMCID: PMC1574906.

61 Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, Corinaldesi R, Barbara G. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol. 2011 Jul;106(7):1290-8. doi: 10.1038/ajg.2011.86. Epub 2011 Mar 22. PMID: 21427712.

62 Bonetto S, Fagoonee S, Battaglia E, Grassini M, Saracco GM, Pellicano R. Recent advances in the treatment of irritable bowel syndrome. Pol Arch Intern Med. 2021 Aug 30;131(7-8):709-715. doi: 10.20452/pamw.16067. Epub 2021 Aug 30. PMID: 34463082.

63 Osadchiy V, Martin CR, Mayer EA. The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications. Clin Gastroenterol Hepatol. 2019 Jan;17(2):322-332. doi: 10.1016/j.cgh.2018.10.002. Epub 2018 Oct 4. PMID: 30292888; PMCID: PMC6999848.

64 Lach G, Schellekens H, Dinan TG, Cryan JF. Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. Neurotherapeutics. 2018 Jan;15(1):36-59. doi: 10.1007/s13311-017-0585-0. PMID: 29134359; PMCID: PMC5794698.

65 Moser G, Fournier C, Peter J. Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wien Med Wochenschr. 2018 Mar;168(3-4):62-66. doi: 10.1007/s10354-017-0592-0. Epub 2017 Sep 8. PMID: 28887729; PMCID: PMC5860136.

66 Kim JH, Lin E, Pimentel M. Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2017 Jan 30;23(1):20-26. doi: 10.5056/jnm16135. PMID: 27817184; PMCID: PMC5216630.

67 Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018 Dec 19;10(472):eaap8914. doi: 10.1126/scitranslmed.aap8914. PMID: 30567928.

68 Jadallah KA, Nimri LF, Ghanem RA. Protozoan parasites in irritable bowel syndrome: A case-control study. World J Gastrointest Pharmacol Ther. 2017 Nov 6;8(4):201-207. doi: 10.4292/wjgpt.v8.i4.201. PMID: 29152406; PMCID: PMC5680167.

69 Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017 Oct 26;6(11):99. doi: 10.3390/jcm6110099. PMID: 29072609; PMCID: PMC5704116.

70 Halpert A. Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education. J Clin Med. 2018 Jan 2;7(1):3. doi: 10.3390/jcm7010003. PMID: 29301273; PMCID: PMC5791011.

71 Hulme K, Chilcot J, Smith MA. Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance. Psychol Health Med. 2018 Jul;23(6):674-684. doi: 10.1080/13548506.2017.1417613. Epub 2017 Dec 20. PMID: 29260889.

72 Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 2009 Aug;11(4):265-9. doi: 10.1007/s11894-009-0039-x. PMID: 19615301.

73 Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010 Apr;105(4):859-65. doi: 10.1038/ajg.2010.55. Epub 2010 Feb 23. PMID: 20179696; PMCID: PMC2887227.

74 Suleiman S, Sonnenberg A. Cost-effectiveness of endoscopy in irritable bowel syndrome. Arch Intern Med. 2001 Feb 12;161(3):369-75. doi: 10.1001/archinte.161.3.369. PMID: 11176762.

75 Hovdenak N. Loperamide treatment of the irritable bowel syndrome. Scand J Gastroenterol Suppl. 1987;130:81-4. doi: 10.3109/00365528709091004. PMID: 3306904.

76 Hanauer SB. The role of loperamide in gastrointestinal disorders. Rev Gastroenterol Disord. 2008 Winter;8(1):15-20. PMID: 18477966.

77 Palmer KR, Corbett CL, Holdsworth CD. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology. 1980 Dec;79(6):1272-5. PMID: 7002706.

78 Lee AA, Baker JR, Wamsteker EJ, Saad R, DiMagno MJ. Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use. Am J Gastroenterol. 2019 Jul;114(7):1163-1171. doi: 10.14309/ajg.0000000000000200. PMID: 31008737; PMCID: PMC6610753.

79 Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg. 2004 Feb;98(2):364-70, table of contents. doi: 10.1213/01.ane.0000097168.32472.0d. PMID: 14742371.

80 Usai-Satta P, Bellini M, Lai M, Oppia F, Cabras F. Therapeutic Approach for Irritable Bowel Syndrome: Old and New Strategies. Curr Clin Pharmacol. 2018;13(3):164-172. doi: 10.2174/1574884713666180807143606. PMID: 30084333.

81 Li J, Zhu W, Liu W, Wu Y, Wu B. Rifaximin for Irritable Bowel Syndrome: A Metaanalysis of Randomized Placebo-Controlled Trials. Medicine (Baltimore). 2016 Jan;95(4):e2534. doi: 10.1097/MD.0000000000002534. PMID: 26825893; PMCID: PMC5291563.

82 Qi Q, Zhang Y, Chen F, Zuo X, Li Y. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol. 2018 Jan 8;18(1):5. doi: 10.1186/s12876-017-0734-2. PMID: 29310568; PMCID: PMC5759234.

83 Ianiro G, Eusebi LH, Black CJ, Gasbarrini A, Cammarota G, Ford AC. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Aug;50(3):240-248. doi: 10.1111/apt.15330. Epub 2019 May 28. PMID: 31136009.

84 Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Clin Ther. 2008 May;30(5):884-901. doi: 10.1016/j.clinthera.2008.05.002. PMID: 18555935.

85 Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S, Enyati N, Pasia G, Maesincee D, Ocon V, Abdulridha M, Longo VD. Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Rep. 2019 Mar 5;26(10):2704-2719.e6. doi: 10.1016/j.celrep.2019.02.019. PMID: 30840892; PMCID: PMC6528490.

86 Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014 May;3(3):16-24. doi: 10.7453/gahmj.2014.019. PMID: 24891990; PMCID: PMC4030608.

87 Pimentel M, Constantino T, Kong Y, Bajwa M, Rezaei A, Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci. 2004 Jan;49(1):73-7. doi: 10.1023/b:ddas.0000011605.43979.e1. PMID: 14992438.

88 Berstad A, Hauso O, Berstad K, Berstad JER. From IBS to ME – The dysbiotic march hypothesis. Med Hypotheses. 2020 Feb 26;140:109648. doi: 10.1016/j.mehy.2020.109648. Epub ahead of print. PMID: 32126475.

89 Struppe T. Symptom-severity, comorbidities and quality of life of patients with Irritable Bowel Syndrome: Insights from a German-speaking online-cohort. 2020. Material gathered from an unpublished draft by Thomas Struppe, Zittau.

 

90 Maes M, Leunis JC. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuro Endocrinol Lett. 2008 Dec;29(6):902-10. PMID: 19112401.

 

1 Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020 Jul 15;12(7):2097. doi: 10.3390/nu12072097. PMID: 32679784; PMCID: PMC7400911.

2 Zittermann A. The estimated benefits of vitamin D for Germany. Mol Nutr Food Res. 2010 Aug;54(8):1164-71. doi: 10.1002/mnfr.200900494. PMID: 20373291.

3 Grant WB, Schuitemaker GE. Health benefits of higher serum 25-hydroxyvitamin D levels in The Netherlands. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):456-8. doi: 10.1016/j.jsbmb.2010.03.089. Epub 2010 Apr 14. PMID: 20398763.

4 Khayyat Y, Attar S. Vitamin D Deficiency in Patients with Irritable Bowel Syndrome: Does it Exist? Oman Med J. 2015 Mar;30(2):115-8. doi: 10.5001/omj.2015.25. PMID: 25960837; PMCID: PMC4412886.

5 Bikle DD. Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2:V50-4. doi: 10.1359/jbmr.07s208. PMID: 18290722.

6 Gominak SC. Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a “pro-inflammatory” state associated with atherosclerosis and autoimmunity. Med Hypotheses. 2016 Sep;94:103-7. doi: 10.1016/j.mehy.2016.07.007. Epub 2016 Jul 14. PMID: 27515213.

7 Tabatabaeizadeh SA, Tafazoli N, Ferns GA, Avan A, Ghayour-Mobarhan M. Vitamin D, the gut microbiome and inflammatory bowel disease. J Res Med Sci. 2018 Aug 23;23:75. doi: 10.4103/jrms.JRMS_606_17. PMID: 30181757; PMCID: PMC6116667.

8 Gubatan J, Moss AC. Vitamin D in inflammatory bowel disease: more than just a supplement. Curr Opin Gastroenterol. 2018 Jul;34(4):217-225. doi: 10.1097/MOG.0000000000000449. PMID: 29762159.

9 Jalili M, Vahedi H, Poustchi H, Hekmatdoost A. Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Int J Prev Med. 2019 Feb 12;10:16. doi: 10.4103/ijpvm.IJPVM_512_17. PMID: 30820303; PMCID: PMC6390425.

10 Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007 Feb;3(2):112-22. PMID: 21960820; PMCID: PMC3099351.

11 Compare D, Pica L, Rocco A, De Giorgi F, Cuomo R, Sarnelli G, Romano M, Nardone G. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest. 2011 Apr;41(4):380-6. doi: 10.1111/j.1365-2362.2010.02419.x. Epub 2010 Dec 3. PMID: 21128930.

12 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011 Aug 23;2:49. doi: 10.3389/fphys.2011.00049. PMID: 21897820; PMCID: PMC3159897.

13 Wang SH, Dong L, Luo JY, Li L, Zhu YL, Wang XQ, Zou BC, Gong J. A research of migrating motor complex in patients with irritable bowel syndrome. Zhonghua Nei Ke Za Zhi. 2009 Feb;48(2):106-10. Chinese. PMID: 19549462.

14 Avelar Rodriguez D, Ryan PM, Toro Monjaraz EM, Ramirez Mayans JA, Quigley EM. Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review. Front Pediatr. 2019 Sep 4;7:363. doi: 10.3389/fped.2019.00363. PMID: 31552207; PMCID: PMC6737284.

15 Rao SSC, Rehman A, Yu S, Andino NM. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol. 2018 Jun 19;9(6):162. doi: 10.1038/s41424-018-0030-7. PMID: 29915215; PMCID: PMC6006167.

16 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017 Mar 15;11(2):196-208. doi: 10.5009/gnl16126. PMID: 28274108; PMCID: PMC5347643.

17 Ghoshal UC, Srivastava D, Misra A, Ghoshal U. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2016 Mar;28(3):281-9. doi: 10.1097/MEG.0000000000000557. PMID: 26731696.

18 Losurdo G, Leandro G, Ierardi E, Perri F, Barone M, Principi M, Leo AD. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis. J Neurogastroenterol Motil. 2020 Jan 30;26(1):16-28. doi: 10.5056/jnm19113. PMID: 31743632; PMCID: PMC6955189.

19 Nickles MA, Hasan A, Shakhbazova A, Wright S, Chambers CJ, Sivamani RK. Alternative Treatment Approaches to Small Intestinal Bacterial Overgrowth: A Systematic Review. J Altern Complement Med. 2021 Feb;27(2):108-119. doi: 10.1089/acm.2020.0275. Epub 2020 Oct 19. PMID: 33074705.

20 Kim MH, Kim H. The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. Int J Mol Sci. 2017 May 12;18(5):1051. doi: 10.3390/ijms18051051. PMID: 28498331; PMCID: PMC5454963.

21 Piche T. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014 Mar;26(3):296-302. doi: 10.1111/nmo.12315. PMID: 24548256.

22 Morris G, Berk M, Carvalho AF, Caso JR, Sanz Y, Maes M. The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue Syndrome. Curr Pharm Des. 2016;22(40):6058-6075. doi: 10.2174/1381612822666160914182822. PMID: 27634186.

23 Long Y, Du L, Kim JJ, Chen B, Zhu Y, Zhang Y, Yao S, He H, Zheng X, Huang Z, Dai N. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice. Neurogastroenterol Motil. 2018 Sep;30(9):e13348. doi: 10.1111/nmo.13348. Epub 2018 Apr 11. PMID: 29644768.

24 Sadeghi A, Biglari M, Nasseri Moghaddam S. Post-infectious Irritable Bowel Syndrome: A Narrative Review. Middle East J Dig Dis. 2019 Apr;11(2):69-75. doi: 10.15171/mejdd.2019.130. Epub 2019 Mar 25. PMID: 31380002; PMCID: PMC6663289.

25 Barbara G, Stanghellini V, Cremon C, De Giorgio R, Corinaldesi R. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. Dig Dis. 2007;25(3):245-8. doi: 10.1159/000103894. PMID: 17827949.

26 Rao R, Samak G. Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions. J Epithel Biol Pharmacol. 2012 Jan;5(Suppl 1-M7):47-54. doi: 10.2174/1875044301205010047. PMID: 25810794; PMCID: PMC4369670.

27 Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome. Biomed Pharmacother. 2021 Jul;139:111649. doi: 10.1016/j.biopha.2021.111649. Epub 2021 May 3. PMID: 33957565.

28 Zhou Q, Verne ML, Fields JZ, Lefante JJ, Basra S, Salameh H, Verne GN. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019 Jun;68(6):996-1002. doi: 10.1136/gutjnl-2017-315136. Epub 2018 Aug 14. PMID: 30108163.

 

29 Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res. 2020 Jan 31;9:F1000 Faculty Rev-69. doi: 10.12688/f1000research.20510.1. PMID: 32051759; PMCID: PMC6996528.

 

1 Corsello A, Pugliese D, Gasbarrini A, Armuzzi A. Diet and Nutrients in Gastrointestinal Chronic Diseases. Nutrients. 2020 Sep 3;12(9):2693. doi: 10.3390/nu12092693. PMID: 32899273; PMCID: PMC7551310.

2 Buscail C, Sabate JM, Bouchoucha M, Kesse-Guyot E, Hercberg S, Benamouzig R, Julia C. Western Dietary Pattern Is Associated with Irritable Bowel Syndrome in the French NutriNet Cohort. Nutrients. 2017 Sep 7;9(9):986. doi: 10.3390/nu9090986. PMID: 28880222; PMCID: PMC5622746.

3 Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 2019 Jul 16;11(7):1613. doi: 10.3390/nu11071613. PMID: 31315227; PMCID: PMC6682904.

4 Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017 Apr 8;15(1):73. doi: 10.1186/s12967-017-1175-y. PMID: 28388917; PMCID: PMC5385025.

5 Werlang ME, Palmer WC, Lacy BE. Irritable Bowel Syndrome and Dietary Interventions. Gastroenterol Hepatol (N Y). 2019 Jan;15(1):16-26. PMID: 30899204; PMCID: PMC6423692.

6 Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Metaanalysis. Nutrients. 2017 Aug 26;9(9):940. doi: 10.3390/nu9090940. PMID: 28846594; PMCID: PMC5622700.

7 Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, Fried M, Dai N. Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther. 2014 Feb;39(3):302-11. doi: 10.1111/apt.12582. Epub 2013 Dec 5. PMID: 24308871.

8 Misselwitz B, Pohl D, Frühauf H, Fried M, Vavricka SR, Fox M. Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United European Gastroenterol J. 2013 Jun;1(3):151-9. doi: 10.1177/2050640613484463. PMID: 24917953; PMCID: PMC4040760.

9 Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017 Aug;66(8):1517-1527. doi: 10.1136/gutjnl-2017-313750. Epub 2017 Jun 7. PMID: 28592442.

10 Suarez FL, Springfield J, Levitt MD. Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour. Gut. 1998 Jul;43(1):100-4. doi: 10.1136/gut.43.1.100. PMID: 9771412; PMCID: PMC1727181.

11 Murray K, Wilkinson-Smith V, Hoad C, Costigan C, Cox E, Lam C, Marciani L, Gowland P, Spiller RC. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol. 2014 Jan;109(1):110-9. doi: 10.1038/ajg.2013.386. Epub 2013 Nov 19. PMID: 24247211; PMCID: PMC3887576.

12 van Lanen AS, de Bree A, Greyling A. Efficacy of a Low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr. 2021 Feb 14. doi: 10.1007/s00394-020-02473-0. Epub ahead of print. Erratum in: Eur J Nutr. 2021 Jun 28;: PMID: 33585949.

13 Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol. 2016 Dec;111(12):1824-1832. doi: 10.1038/ajg.2016.434. Epub 2016 Oct 11. PMID: 27725652.

14 Zhou SY, Gillilland M 3rd, Wu X, Leelasinjaroen P, Zhang G, Zhou H, Ye B, Lu Y, Owyang C. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest. 2018 Jan 2;128(1):267-280. doi: 10.1172/JCI92390. Epub 2017 Nov 27. PMID: 29202473; PMCID: PMC5749529.

15 McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, Madsen K, Bercik P, Vanner S. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017 Jul;66(7):1241-1251. doi: 10.1136/gutjnl-2015-311339. Epub 2016 Mar 14. Erratum in: Gut. 2019 Jul;68(7):1342. PMID: 26976734.

16 Varney J, Barrett J, Scarlata K, Catsos P, Gibson PR, Muir JG. FODMAPs: food composition, defining cutoff values and international application. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:53-61. doi: 10.1111/jgh.13698. PMID: 28244665.

17 Paglia L. The sweet danger of added sugars. Eur J Paediatr Dent. 2019 Jun;20(2):89. doi: 10.23804/ejpd.2019.20.02.01. PMID: 31246081.

18 Zinöcker MK, Lindseth IA. The Western Diet-Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients. 2018 Mar 17;10(3):365. doi: 10.3390/nu10030365. PMID: 29562591; PMCID: PMC5872783.

19 Bascuñán KA, Elli L, Pellegrini N, Scricciolo A, Lombardo V, Doneda L, Vecchi M, Scarpa C, Araya M, Roncoroni L. Impact of FODMAP Content Restrictions on the Quality of Diet for Patients with Celiac Disease on a Gluten-Free Diet. Nutrients. 2019 Sep 14;11(9):2220. doi: 10.3390/nu11092220. PMID: 31540014; PMCID: PMC6770200.

20 Staudacher HM, Ralph FSE, Irving PM, Whelan K, Lomer MCE. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet. J Acad Nutr Diet. 2020 Apr;120(4):535-547. doi: 10.1016/j.jand.2019.01.017. Epub 2019 Apr 24. Erratum in: J Acad Nutr Diet. 2020 Dec;120(12):2098. PMID: 31029650.

21 Staudacher HM. Nutritional, microbiological and psychosocial implications of the low FODMAP diet. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:16-19. doi: 10.1111/jgh.13688. PMID: 28244658.

22 Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, Ibraim SB, Roume H, Levenez F, Pons N, Maziers N, Lomer MC, Ehrlich SD, Irving PM, Whelan K. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology. 2020 Jan;158(1):176-188.e7. doi: 10.1053/j.gastro.2019.09.024. Epub 2019 Oct 2. PMID: 31586453.

23 Aziz I, Branchi F, Pearson K, Priest J, Sanders DS. A study evaluating the bidirectional relationship between inflammatory bowel disease and self-reported non-celiac gluten sensitivity. Inflamm Bowel Dis. 2015 Apr;21(4):847-53. doi: 10.1097/MIB.0000000000000335. PMID: 25719528.

24 Barone M, Gemello E, Viggiani MT, Cristofori F, Renna C, Iannone A, Di Leo A, Francavilla R. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients. 2020 Mar 6;12(3):705. doi: 10.3390/nu12030705. PMID: 32155878; PMCID: PMC7146412.

25 Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, Zevallos V, Libermann TA, Dillon S, Freitag TL, Kelly CP, Schuppan D. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012 Dec 17;209(13):2395-408. doi: 10.1084/jem.20102660. Epub 2012 Dec 3. PMID: 23209313; PMCID: PMC3526354.

26 Zevallos VF, Raker V, Tenzer S, Jimenez-Calvente C, Ashfaq-Khan M, Rüssel N, Pickert G, Schild H, Steinbrink K, Schuppan D. Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells. Gastroenterology. 2017 Apr;152(5):1100-1113.e12. doi: 10.1053/j.gastro.2016.12.006. Epub 2016 Dec 16. PMID: 27993525.

27 Brown SR, Cann PA, Read NW. Effect of coffee on distal colon function. Gut. 1990 Apr;31(4):450-3. doi: 10.1136/gut.31.4.450. PMID: 2338272; PMCID: PMC1378422.

28 Rao SS, Welcher K, Zimmerman B, Stumbo P. Is coffee a colonic stimulant? Eur J Gastroenterol Hepatol. 1998 Feb;10(2):113-8. doi: 10.1097/00042737-199802000-00003. PMID: 9581985.

29 Boekema PJ, Samsom M, van Berge Henegouwen GP, Smout AJ. Coffee and gastrointestinal function: facts and fiction. A review. Scand J Gastroenterol Suppl. 1999;230:35-9. doi: 10.1080/003655299750025525. PMID: 10499460.

30 Lovallo WR, Al'Absi M, Blick K, Whitsett TL, Wilson MF. Stress-like adrenocorticotropin responses to caffeine in young healthy men. Pharmacol Biochem Behav. 1996 Nov;55(3):365-9. doi: 10.1016/s0091-3057(96)00105-0. PMID: 8951977.

31 Patacchioli FR, Angelucci L, Dellerba G, Monnazzi P, Leri O. Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS). J Endocrinol Invest. 2001 Mar;24(3):173-7. doi: 10.1007/BF03343838. PMID: 11314746.

32 Koochakpoor G, Salari-Moghaddam A, Keshteli AH, Esmaillzadeh A, Adibi P. Association of Coffee and Caffeine Intake With Irritable Bowel Syndrome in Adults. Front Nutr. 2021 Jun 15;8:632469. doi: 10.3389/fnut.2021.632469. PMID: 34211993; PMCID: PMC8241212.

33 Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000 Dec;95(12):3374-82. doi: 10.1111/j.1572-0241.2000.03347.x. PMID: 11151864.

34 Gabbard SL, Lacy BE, Levine GM, Crowell MD. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci. 2014 Mar;59(3):638-44. doi: 10.1007/s10620-013-2960-y. Epub 2013 Dec 10. PMID: 24323179.

35 Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006 Nov;18(11):1001-8. doi: 10.1111/j.1365-2982.2006.00815.x. PMID: 17040411.

36 Ernst, J.B., Arens-Azevêdo, U., Bitzer, B., Bosy-Westphal, A., Zwaan, M., Egert, S., Fritsche, A., Gerlach, S., Hauner, H., Heseker, H., Koletzko, B., Dirk, Müller-Wieland, Schulze, M., Virmani, K., Watzl, B., & Buyken, A. (2019). Quantitative recommendation on sugar intake in Germany Short version of the consensus paper by the German Obesity Society ( DAG ) , German Diabetes Society ( DDG ) and German Nutrition Society ( DGE ).

37 Satokari R. High Intake of Sugar and the Balance between Pro- and Anti-Inflammatory Gut Bacteria. Nutrients. 2020 May 8;12(5):1348. doi: 10.3390/nu12051348. PMID: 32397233; PMCID: PMC7284805.

38 Khan S, Waliullah S, Godfrey V, Khan MAW, Ramachandran RA, Cantarel BL, Behrendt C, Peng L, Hooper LV, Zaki H. Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice. Sci Transl Med. 2020 Oct 28;12(567):eaay6218. doi: 10.1126/scitranslmed.aay6218. PMID: 33115951.

39 Fajstova A, Galanova N, Coufal S, Malkova J, Kostovcik M, Cermakova M, Pelantova H, Kuzma M, Sediva B, Hudcovic T, Hrncir T, Tlaskalova-Hogenova H, Kverka M, Kostovcikova K. Diet Rich in Simple Sugars Promotes Pro-Inflammatory Response via Gut Microbiota Alteration and TLR4 Signaling. Cells. 2020 Dec 16;9(12):2701. doi: 10.3390/cells9122701. PMID: 33339337; PMCID: PMC7766268.

40 Khademi Z, Milajerdi A, Larijani B, Esmaillzadeh A. Dietary Intake of Total Carbohydrates, Sugar and Sugar-Sweetened Beverages, and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Front Nutr. 2021 Oct 1;8:707795. doi: 10.3389/fnut.2021.707795. PMID: 34660658; PMCID: PMC8517080.

41 Brandes JW, Lorenz-Meyer H. Zuckerfreie Diät: Ein neue Perspektive zur Behandlung des Morbus Crohn? Eine randomisierte, kontrollierte Studie [Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized control study]. Z Gastroenterol. 1981 Jan;19(1):1-12. German. PMID: 7013307.

42 Laudisi F, Stolfi C, Monteleone G. Impact of Food Additives on Gut Homeostasis. Nutrients. 2019 Oct 1;11(10):2334. doi: 10.3390/nu11102334. PMID: 31581570; PMCID: PMC6835893.

43 Rinninella E, Cintoni M, Raoul P, Gasbarrini A, Mele MC. Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track. Int J Environ Res Public Health. 2020 Nov 27;17(23):8816. doi: 10.3390/ijerph17238816. PMID: 33260947; PMCID: PMC7730902.

44 Ghosh S, Molcan E, DeCoffe D, Dai C, Gibson DL. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice. Br J Nutr. 2013 Aug 28;110(3):515-23. doi: 10.1017/S0007114512005326. Epub 2013 Jan 8. PMID: 23298440.

45 Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. Health implications of high dietary omega-6 polyunsaturated Fatty acids. J Nutr Metab. 2012;2012:539426. doi: 10.1155/2012/539426. Epub 2012 Apr 5. PMID: 22570770; PMCID: PMC3335257.

46 Sugizaki CSA, Naves MMV. Potential Prebiotic Properties of Nuts and Edible Seeds and Their Relationship to Obesity. Nutrients. 2018 Nov 3;10(11):1645. doi: 10.3390/nu10111645. PMID: 30400274; PMCID: PMC6266159.

47 Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl). 2004 Oct;176(1):1-29. doi: 10.1007/s00213-004-2000-x. Epub 2004 Sep 21. PMID: 15448977.

48 Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev. 2008;32(1):20-39. doi: 10.1016/j.neubiorev.2007.04.019. Epub 2007 May 18. PMID: 17617461; PMCID: PMC2235907.

49 Wiss DA, Avena N, Rada P. Sugar Addiction: From Evolution to Revolution. Front Psychiatry. 2018 Nov 7;9:545. doi: 10.3389/fpsyt.2018.00545. PMID: 30464748; PMCID: PMC6234835.

50 Takahashi M, Fukunaga H, Kaneto H, Fukudome S, Yoshikawa M. Behavioral and pharmacological studies on gluten exorphin A5, a newly isolated bioactive food protein fragment, in mice. Jpn J Pharmacol. 2000 Nov;84(3):259-65. doi: 10.1254/jjp.84.259. PMID: 11138726.

51 Guasch-Ferré M, Willett WC. The Mediterranean diet and health: a comprehensive overview. J Intern Med. 2021 Sep;290(3):549-566. doi: 10.1111/joim.13333. Epub 2021 Aug 23. PMID: 34423871.

52 Zito FP, Polese B, Vozzella L, Gala A, Genovese D, Verlezza V, Medugno F, Santini A, Barrea L, Cargiolli M, Andreozzi P, Sarnelli G, Cuomo R. Good adherence to mediterranean diet can prevent gastrointestinal symptoms: A survey from Southern Italy. World J Gastrointest Pharmacol Ther. 2016 Nov 6;7(4):564-571. doi: 10.4292/wjgpt.v7.i4.564. PMID: 27867690; PMCID: PMC5095576.

53 Agakidis C, Kotzakioulafi E, Petridis D, Apostolidou K, Karagiozoglou-Lampoudi T. Mediterranean Diet Adherence is Associated with Lower Prevalence of Functional Gastrointestinal Disorders in Children and Adolescents. Nutrients. 2019 Jun 6;11(6):1283. doi: 10.3390/nu11061283. PMID: 31174310; PMCID: PMC6628326.

54 Merra G, Noce A, Marrone G, Cintoni M, Tarsitano MG, Capacci A, De Lorenzo A. Influence of Mediterranean Diet on Human Gut Microbiota. Nutrients. 2020 Dec 22;13(1):7. doi: 10.3390/nu13010007. PMID: 33375042; PMCID: PMC7822000.

55 García-Montero C, Fraile-Martínez O, Gómez-Lahoz AM, Pekarek L, Castellanos AJ, Noguerales-Fraguas F, Coca S, Guijarro LG, García-Honduvilla N, Asúnsolo A, Sanchez-Trujillo L, Lahera G, Bujan J, Monserrat J, Álvarez-Mon M, Álvarez-Mon MA, Ortega MA. Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota-Immune System Interplay. Implications for Health and Disease. Nutrients. 2021 Feb 22;13(2):699. doi: 10.3390/nu13020699. PMID: 33671569; PMCID: PMC7927055.

56 Chicco F, Magrì S, Cingolani A, Paduano D, Pesenti M, Zara F, Tumbarello F, Urru E, Melis A, Casula L, Fantini MC, Usai P. Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflamm Bowel Dis. 2021 Jan 1;27(1):1-9. doi: 10.1093/ibd/izaa097. PMID: 32440680; PMCID: PMC7737160.

57 Pinart M, Jeran S, Boeing H, Stelmach-Mardas M, Standl M, Schulz H, Harris C, von Berg A, Herberth G, Koletzko S, Linseisen J, Breuninger TA, Nöthlings U, Barbaresko J, Benda S, Lachat C, Yang C, Gasparini P, Robino A, Rojo-Martínez G, Castaño L, Guillaume M, Donneau AF, Hoge A, Gillain N, Avraam D, Burton PR, Bouwman J, Pischon T, Nimptsch K. Dietary Macronutrient Composition in Relation to Circulating HDL and Non-HDL Cholesterol: A Federated Individual-Level Analysis of Cross-Sectional Data from Adolescents and Adults in 8 European Studies. J Nutr. 2021 Aug 7;151(8):2317-2329. doi: 10.1093/jn/nxab077. PMID: 33847346.

58 Saidi K, Nilholm C, Roth B, Ohlsson B. A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction. Nutr Res. 2021 Feb;86:23-36. doi: 10.1016/j.nutres.2020.12.001. Epub 2020 Dec 4. PMID: 33450656.

59 Windey K, De Preter V, Verbeke K. Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2012 Jan;56(1):184-96. doi: 10.1002/mnfr.201100542. Epub 2011 Nov 25. PMID: 22121108.

60 Gibson PR, Barrett JS, Muir JG. Functional bowel symptoms and diet. Intern Med J. 2013 Oct;43(10):1067-74. doi: 10.1111/imj.12266. PMID: 24134168.

61 Guadagni M, Biolo G. Effects of inflammation and/or inactivity on the need for dietary protein. Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):617-22. doi: 10.1097/MCO.0b013e32833193bd. PMID: 19741515.

62 Salvioli B, Serra J, Azpiroz F, Malagelada JR. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol. 2006 Aug;101(8):1853-7. doi: 10.1111/j.1572-0241.2006.00702.x. Epub 2006 Jun 30. PMID: 16817837.

63 Feinle-Bisset C, Azpiroz F. Dietary lipids and functional gastrointestinal disorders. Am J Gastroenterol. 2013 May;108(5):737-47. doi: 10.1038/ajg.2013.76. Epub 2013 Apr 9. PMID: 23567355.

64 Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J, Li H, Wang R, Tang J, Huang T, Zheng J, Sinclair AJ, Mann J, Li D. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut. 2019 Aug;68(8):1417-1429. doi: 10.1136/gutjnl-2018-317609. Epub 2019 Feb 19. PMID: 30782617.

65 Machate DJ, Figueiredo PS, Marcelino G, Guimarães RCA, Hiane PA, Bogo D, Pinheiro VAZ, Oliveira LCS, Pott A. Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis. Int J Mol Sci. 2020 Jun 8;21(11):4093. doi: 10.3390/ijms21114093. PMID: 32521778; PMCID: PMC7312778.

66 Parisio C , Lucarini E , Micheli L , Toti A , Bellumori M , Cecchi L , Calosi L , Bani D , Di Cesare Mannelli L , Mulinacci N , Ghelardini C . Extra virgin olive oil and related by-products (Olea europaea L.) as natural sources of phenolic compounds for abdominal pain relief in gastrointestinal disorders in rats. Food Funct. 2020 Dec 1;11(12):10423-10435. doi: 10.1039/d0fo02293d. Epub 2020 Nov 25. PMID: 33237043.

67 Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL. Health benefits of dietary fiber. Nutr Rev. 2009 Apr;67(4):188-205. doi: 10.1111/j.1753-4887.2009.00189.x. PMID: 19335713.

68 Daïen CI, Pinget GV, Tan JK, Macia L. Detrimental Impact of Microbiota-Accessible Carbohydrate-Deprived Diet on Gut and Immune Homeostasis: An Overview. Front Immunol. 2017 May 12;8:548. doi: 10.3389/fimmu.2017.00548. PMID: 28553291; PMCID: PMC5427073.

69 El-Salhy M, Ystad SO, Mazzawi T, Gundersen D. Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med. 2017 Sep;40(3):607-613. doi: 10.3892/ijmm.2017.3072. Epub 2017 Jul 19. PMID: 28731144; PMCID: PMC5548066.

70 Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, Moayyedi P. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008 Nov 13;337:a2313. doi: 10.1136/bmj.a2313. Erratum in: BMJ.2009;338:b1881. PMID: 19008265; PMCID: PMC2583392.

71 Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, de Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004 Feb 1;19(3):245-51. doi: 10.1111/j.0269-2813.2004.01862.x. PMID: 14984370.

72 El-Salhy M, Ystad SO, Mazzawi T, Gundersen D. Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med. 2017 Sep;40(3):607-613. doi: 10.3892/ijmm.2017.3072. Epub 2017 Jul 19. PMID: 28731144; PMCID: PMC5548066.

73 Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, Topf M, Gonzalez CG, Van Treuren W, Han S, Robinson JL, Elias JE, Sonnenburg ED, Gardner CD, Sonnenburg JL. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021 Aug 5;184(16):4137-4153.e14. doi: 10.1016/j.cell.2021.06.019. Epub 2021 Jul 12. PMID: 34256014.

74 Ho KS, Tan CY, Mohd Daud MA, Seow-Choen F. Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms. World J Gastroenterol. 2012 Sep 7;18(33):4593-6. doi: 10.3748/wjg.v18.i33.4593. PMID: 22969234; PMCID: PMC3435786.

75 Mazzawi T, El-Salhy M. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med. 2017 Oct;40(4):943-952. doi: 10.3892/ijmm.2017.3096. Epub 2017 Aug 11. PMID: 28849091; PMCID: PMC5593462.

76 Zaribaf F, Keshteli AH, Esmaillzadeh A, Saneei P, Feizi A, Daghaghzadeh H, Feinle-Bisset C, Adibi P. Empirically derived dietary habits are associated with irritable bowel syndrome. Eur J Clin Nutr. 2018 Nov;72(11):1537-1547. doi: 10.1038/s41430-018-0109-y. Epub 2018 Mar 13. PMID: 29535405.

77 Gabel K, Marcell J, Cares K, Kalam F, Cienfuegos S, Ezpeleta M, Varady KA. Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study. Nutr Health. 2020 Jun;26(2):79-85. doi: 10.1177/0260106020910907. Epub 2020 Mar 30. PMID: 32228124.

78 Witbracht M, Keim NL, Forester S, Widaman A, Laugero K. Female breakfast skippers display a disrupted cortisol rhythm and elevated blood pressure. Physiol Behav. 2015 Mar 1;140:215-21. doi: 10.1016/j.physbeh.2014.12.044. Epub 2014 Dec 27. PMID: 25545767.

79 Vakhshuury M, Khoshdel A. The Relation between Dietary Patterns and Functional Gastrointestinal Disorders among Iranian Military Men. Adv Biomed Res. 2019 Jan 21;8:2. doi: 10.4103/abr.abr_180_18. PMID: 30775344; PMCID: PMC6357671.

80 Gulcan E, Taser F, Toker A, Korkmaz U, Alcelik A. Increased frequency of prediabetes in patients with irritable bowel syndrome. Am J Med Sci. 2009 Aug;338(2):116-9. doi: 10.1097/MAJ.0b013e31819f7587. PMID: 19561452.

81 Ghadiri-Anari A, Gholami S, Zolfaghari F, Namiranian N. Prediabetes and gastrointestinal (GI) symptoms; a cross-sectional study. Diabetes Metab Syndr. 2019 Jan-Feb;13(1):844-846. doi: 10.1016/j.dsx.2018.12.005. Epub 2018 Dec 8. PMID: 30641819.

82 Altuntaş Y. Postprandial Reactive Hypoglycemia. Sisli Etfal Hastan Tip Bul. 2019 Aug 28;53(3):215-220. doi: 10.14744/SEMB.2019.59455. PMID: 32377086; PMCID: PMC7192270.

83 Cherpak CE. Mindful Eating: A Review Of How The Stress-Digestion-Mindfulness Triad May Modulate And Improve Gastrointestinal And Digestive Function. Integr Med (Encinitas). 2019 Aug;18(4):48-53. PMID: 32549835; PMCID: PMC7219460.

84 Salari-Moghaddam A, Hassanzadeh Keshteli A, Esmaillzadeh A, Adibi P. Water consumption and prevalence of irritable bowel syndrome among adults. PLoS One. 2020 Jan 24;15(1):e0228205. doi: 10.1371/journal.pone.0228205. PMID: 31978193; PMCID: PMC6980581.

85 Khayyatzadeh SS, Kazemi-Bajestani SMR, Mirmousavi SJ, Heshmati M, Khoshmohabbat S, Ferns GA, Ghayour-Mobarhan M. Dietary behaviors in relation to prevalence of irritable bowel syndrome in adolescent girls. J Gastroenterol Hepatol. 2018 Feb;33(2):404-410. doi: 10.1111/jgh.13908. PMID: 28770579.

86 Nakamura Y, Watanabe H, Tanaka A, Yasui M, Nishihira J, Murayama N. Effect of Increased Daily Water Intake and Hydration on Health in Japanese Adults. Nutrients. 2020 Apr 23;12(4):1191. doi: 10.3390/nu12041191. PMID: 32340375; PMCID: PMC7231288.

87 Zuo XL, Li YQ, Shi L, Lv GP, Kuang RG, Lu XF, Li JM, Desmond PV. Visceral hypersensitivity following cold water intake in subjects with irritable bowel syndrome. J Gastroenterol. 2006 Apr;41(4):311-7. doi: 10.1007/s00535-005-1766-x. PMID: 16741609.

88 Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet. 2018 Apr;31(2):239-255. doi: 10.1111/jhn.12530. Epub 2018 Jan 15. PMID: 29336079.

89 Hill P, Muir JG, Gibson PR. Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y). 2017 Jan;13(1):36-45. PMID: 28420945; PMCID: PMC5390324.

90 Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E227-37. doi: 10.1152/ajpendo.90245.2008. Epub 2008 Apr 8. PMID: 18398011; PMCID: PMC2652499.

91 Tuck C, Barrett J. Re-challenging FODMAPs: the low FODMAP diet phase two. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:11-15. doi: 10.1111/jgh.13687. PMID: 28244664.

92 Mullins AP, Arjmandi BH. Health Benefits of Plant-Based Nutrition: Focus on Beans in Cardiometabolic Diseases. Nutrients. 2021 Feb 5;13(2):519. doi: 10.3390/nu13020519. PMID: 33562498; PMCID: PMC7915747.

93 Ezz El-Arab AM, Girgis SM, Hegazy EM, Abd El-Khalek AB. Effect of dietary honey on intestinal microflora and toxicity of mycotoxins in mice. BMC Complement Altern Med. 2006 Mar 14;6:6. doi: 10.1186/1472-6882-6-6. PMID: 16533410; PMCID: PMC1431562.

94 Vasto S, Rizzo C, Caruso C. Centenarians and diet: what they eat in the Western part of Sicily. Immun Ageing. 2012 Apr 23;9(1):10. doi: 10.1186/1742-4933-9-10. PMID: 22524271; PMCID: PMC3412743.

95 Chumpitazi BP. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders. Curr Opin Gastroenterol. 2020 Mar;36(2):147-154. doi: 10.1097/MOG.0000000000000608. PMID: 31850930; PMCID: PMC7425749.

 

96 Valeur J, Småstuen MC, Knudsen T, Lied GA, Røseth AG. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome. Dig Dis Sci. 2018 Feb;63(2):429-436. doi: 10.1007/s10620-017-4893-3. Epub 2018 Jan 4. PMID: 29302878.

 

1 Grimaldi R, Cela D, Swann JR, Vulevic J, Gibson GR, Tzortzis G, Costabile A. In vitro fermentation of B-GOS: impact on faecal bacterial populations and metabolic activity in autistic and non-autistic children. FEMS Microbiol Ecol. 2017 Feb;93(2):fiw233. doi: 10.1093/femsec/fiw233. Epub 2016 Nov 16. PMID: 27856622; PMCID: PMC5155555.

2 Vulevic J, Tzortzis G, Juric A, Gibson GR. Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence. Neurogastroenterol Motil. 2018 Nov;30(11):e13440. doi: 10.1111/nmo.13440. Epub 2018 Aug 15. PMID: 30109908.

3 Giannini EG, Mansi C, Dulbecco P, Savarino V. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition. 2006 Mar;22(3):334-42. doi: 10.1016/j.nut.2005.10.003. Epub 2006 Jan 18. PMID: 16413751.

4 Chouinard LE. The role of psyllium fibre supplementation in treating irritable bowel syndrome. Can J Diet Pract Res. 2011 Spring;72(1):e107-14. doi: 10.3148/72.1.2011.48. PMID: 21382232.

5 Yang C, Liu S, Li H, Bai X, Shan S, Gao P, Dong X. The effects of psyllium husk on gut microbiota composition and function in chronically constipated women of reproductive age using 16S rRNA gene sequencing analysis. Aging (Albany NY). 2021 Jun 3;13(11):15366-15383. doi: 10.18632/aging.203095. Epub 2021 Jun 3. PMID: 34081625; PMCID: PMC8221300.

6 Jalanka J, Major G, Murray K, Singh G, Nowak A, Kurtz C, Silos-Santiago I, Johnston JM, de Vos WM, Spiller R. The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls. Int J Mol Sci. 2019 Jan 20;20(2):433. doi: 10.3390/ijms20020433. PMID: 30669509; PMCID: PMC6358997.

7 Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006 Jun;100(6):1171-85. doi: 10.1111/j.1365-2672.2006.02963.x. PMID: 16696665.

8 Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM, Dequenne I, de Timary P, Cani PD. How Probiotics Affect the Microbiota. Front Cell Infect Microbiol. 2020 Jan 15;9:454. doi: 10.3389/fcimb.2019.00454. PMID: 32010640; PMCID: PMC6974441.

9 Chan M, Liu D, Wu Y, Yang F, Howell K. Microorganisms in Whole Botanical Fermented Foods Survive Processing and Simulated Digestion to Affect Gut Microbiota Composition. Front Microbiol. 2021 Dec 7;12:759708. doi: 10.3389/fmicb.2021.759708. PMID: 35035384; PMCID: PMC8757042.

10 He J, Li F, Wang Y, Wu H, Yang H. Fermentation characteristics and bacterial dynamics during Chinese sauerkraut fermentation by Lactobacillus curvatus LC-20 under varied salt concentrations reveal its potential in low-salt suan cai production. J Biosci Bioeng. 2021 Jul;132(1):33-40. doi: 10.1016/j.jbiosc.2021.03.009. Epub 2021 Apr 15. PMID: 33865692.

11 Staudacher HM, Scholz M, Lomer MC, Ralph FS, Irving PM, Lindsay JO, Fava F, Tuohy K, Whelan K. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clin Nutr. 2021 Apr;40(4):1861-1870. doi: 10.1016/j.clnu.2020.10.013. Epub 2020 Oct 23. PMID: 33183883.

12 Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases. 2020 Apr 26;8(8):1361-1384. doi: 10.12998/wjcc.v8.i8.1361. Erratum in: World J Clin Cases. 2021 Jul 16;9(20):5752-5753. PMID: 32368530; PMCID: PMC7190945.

13 Legrand R, Nuemi G, Poulain M, Manckoundia P. Description of Lifestyle, Including Social Life, Diet and Physical Activity, of People ≥90 years Living in Ikaria, a Longevity Blue Zone. Int J Environ Res Public Health. 2021 Jun 19;18(12):6602. doi: 10.3390/ijerph18126602. PMID: 34205297; PMCID: PMC8296328.

14 Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2016 Sep;44(5):447-59. doi: 10.1111/apt.13706. Epub 2016 Jul 11. PMID: 27397586.

15 Turan B, Bengi G, Cehreli R, Akpınar H, Soytürk M. Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study. World J Clin Cases. 2021 Sep 6;9(25):7417-7432. doi: 10.12998/wjcc.v9.i25.7417. PMID: 34616808; PMCID: PMC8464468.

16 Rastgoo S, Ebrahimi-Daryani N, Agah S, Karimi S, Taher M, Rashidkhani B, Hejazi E, Mohseni F, Ahmadzadeh M, Sadeghi A, Hekmatdoost A. Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management. Front Nutr. 2021 Dec 16;8:746703. doi: 10.3389/fnut.2021.746703. PMID: 34977110; PMCID: PMC8716871.

17 Buscail C, Sabate JM, Bouchoucha M, Torres MJ, Allès B, Hercberg S, Benamouzig R, Julia C. Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort. PLoS One. 2017 Aug 25;12(8):e0183039. doi: 10.1371/journal.pone.0183039. PMID: 28841661; PMCID: PMC5571937.

18 Ghoshal UC, Singh R. Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population. J Gastroenterol Hepatol. 2017 Feb;32(2):378-387. doi: 10.1111/jgh.13465. PMID: 27262283.

19 Bakaloudi DR, Halloran A, Rippin HL, Oikonomidou AC, Dardavesis TI, Williams J, Wickramasinghe K, Breda J, Chourdakis M. Intake and adequacy of the vegan diet. A systematic review of the evidence. Clin Nutr. 2021 May;40(5):3503-3521. doi: 10.1016/j.clnu.2020.11.035. Epub 2020 Dec 7. PMID: 33341313.

20 Murphy SP, Allen LH. Nutritional importance of animal source foods. J Nutr. 2003 Nov;133(11 Suppl 2):3932S-3935S. doi: 10.1093/jn/133.11.3932S. PMID: 14672292.

21 Sho H. History and characteristics of Okinawan longevity food. Asia Pac J Clin Nutr. 2001;10(2):159-64. doi: 10.1111/j.1440-6047.2001.00235.x. PMID: 11710358.

22 Britto S, Kellermayer R. Carbohydrate Monotony as Protection and Treatment for Inflammatory Bowel Disease. J Crohns Colitis. 2019 Jul 25;13(7):942-948. doi: 10.1093/ecco-jcc/jjz011. PMID: 30715243.

23 Konijeti GG, Kim N, Lewis JD, Groven S, Chandrasekaran A, Grandhe S, Diamant C, Singh E, Oliveira G, Wang X, Molparia B, Torkamani A. Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 Nov;23(11):2054-2060. doi: 10.1097/MIB.0000000000001221. PMID: 28858071; PMCID: PMC5647120.

24 Barone M, Turroni S, Rampelli S, Soverini M, D'Amico F, Biagi E, Brigidi P, Troiani E, Candela M. Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context. PLoS One. 2019 Aug 8;14(8):e0220619. doi: 10.1371/journal.pone.0220619. PMID: 31393934; PMCID: PMC6687155.

25 Gibson PR, Shepherd SJ. Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1399-409. doi: 10.1111/j.1365-2036.2005.02506.x. PMID: 15948806.

 

26 Kosulwat V. The nutrition and health transition in Thailand. Public Health Nutr. 2002 Feb;5(1A):183-9. doi: 10.1079/PHN2001292. PMID: 12027283.

 

1 Wilson B, Cox SR, Whelan K. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proc Nutr Soc. 2021 Feb;80(1):19-28. doi: 10.1017/S0029665120006990. Epub 2020 May 29. PMID: 32468985.

2 Ho MH, Wong WH, Chang C. Clinical spectrum of food allergies: a comprehensive review. Clin Rev Allergy Immunol. 2014 Jun;46(3):225-40. doi: 10.1007/s12016-012-8339-6. PMID: 23229594.

3 Mekkel G, Barta Z, Ress Z, Gyimesi E, Sipka S, Zeher M. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases]. Orv Hetil. 2005 Apr 24;146(17):797-802. Hungarian. PMID: 17918636.

4 Bischoff SC, Mayer J, Wedemeyer J, Meier PN, Zeck-Kapp G, Wedi B, Kapp A, Cetin Y, Gebel M, Manns MP. Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut. 1997 Jun;40(6):745-53. doi: 10.1136/gut.40.6.745. PMID: 9245928; PMCID: PMC1027199.

5 Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004 Oct;53(10):1459-64. doi: 10.1136/gut.2003.037697. PMID: 15361495; PMCID: PMC1774223.

6 Ostrowska L, Wasiluk D, Lieners CFJ, Gałęcka M, Bartnicka A, Tveiten D. Igg Food Antibody Guided Elimination-Rotation Diet Was More Effective than FODMAP Diet and Control Diet in the Treatment of Women with Mixed IBS-Results from an Open Label Study. J Clin Med. 2021 Sep 23;10(19):4317. doi: 10.3390/jcm10194317. PMID: 34640335; PMCID: PMC8509634.

7 Setinova, I., Havranova, M., Dankova, E., & Vorlickova, M. (2015). Diagnostic value of the lymphocyte transformation test for non-IgE mediated food allergy. Clinical and Translational Allergy, 5(Suppl 3), P31. https://doi.org/10.1186/2045-7022-5-S3-P31.

8 Schwab D, Raithel M, Klein P, Winterkamp S, Weidenhiller M, Radespiel-Troeger M, Hochberger J, Hahn EG. Immunoglobulin E and eosinophilic cationic protein in segmental lavage fluid of the small and large bowel identify patients with food allergy. Am J Gastroenterol. 2001 Feb;96(2):508-14. doi: 10.1111/j.1572-0241.2001.03467.x. PMID: 11232698.

9 Aguilera-Lizarraga J, Florens M, Hussein H, Boeckxstaens G. Local immune response as novel disease mechanism underlying abdominal pain in patients with irritable bowel syndrome. Acta Clin Belg. 2021 Oct 28:1-8. doi: 10.1080/17843286.2021.1996069. Epub ahead of print. PMID: 34709996.

10 Ahlström MG, Thyssen JP, Menné T, Johansen JD. Prevalence of nickel allergy in Europe following the EU Nickel Directive – a review. Contact Dermatitis. 2017 Oct;77(4):193-200. doi: 10.1111/cod.12846. Epub 2017 Jul 21. PMID: 28730624.

11 Ricciardi L, Arena A, Arena E, Zambito M, Ingrassia A, Valenti G, Loschiavo G, D'Angelo A, Saitta S. Systemic nickel allergy syndrome: epidemiological data from four Italian allergy units. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):131-6. doi: 10.1177/039463201402700118. PMID: 24674689.

12 Heyman M. Gut barrier dysfunction in food allergy. Eur J Gastroenterol Hepatol. 2005 Dec;17(12):1279-85. doi: 10.1097/00042737-200512000-00003. PMID: 16292078.

13 Kageyama Y, Aida K, Kawauchi K, Morimoto M, Akiyama T, Nakamura T. Higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome. Immun Inflamm Dis. 2019 Dec;7(4):304-307. doi: 10.1002/iid3.274. Epub 2019 Oct 24. PMID: 31647193; PMCID: PMC6842818.

14 Rizzi A, Nucera E, Laterza L, Gaetani E, Valenza V, Corbo GM, Inchingolo R, Buonomo A, Schiavino D, Gasbarrini A. Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet? J Neurogastroenterol Motil. 2017 Jan 30;23(1):101-108. doi: 10.5056/jnm16027. PMID: 28049864; PMCID: PMC5216640.

15 Ständer S, Oppel E, Thomas P, Summer B. Evaluation of lymphocyte transformation tests as compared with patch tests in nickel allergy diagnosis. Contact Dermatitis. 2017 Apr;76(4):228-234. doi: 10.1111/cod.12751. Epub 2017 Feb 7. PMID: 28176340.

16 Austin GL, Dalton CB, Hu Y, Morris CB, Hankins J, Weinland SR, Westman EC, Yancy WS Jr, Drossman DA. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009 Jun;7(6):706-708.e1. doi: 10.1016/j.cgh.2009.02.023. Epub 2009 Mar 10. PMID: 19281859; PMCID: PMC2693479.

17 Dwyer DD, Darville RL. Specific Carbohydrate Diet: Irritable Bowel Syndrome patient case study. Nutrition & Food Science. 45(6). doi: 10.1108/NFS-05-2015-0056.

18 Ohlsson B. Theories behind the effect of starch  and sucrose reduced diets on gastrointestinal symptoms in irritable bowel syndrome (Review). Mol Med Rep. 2021 Oct;24(4):732. doi: 10.3892/mmr.2021.12372. Epub 2021 Aug 20. PMID: 34414452; PMCID: PMC8404103.

19 Garcia-Etxebarria K, Zheng T, Bonfiglio F, Bujanda L, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B, Simren M, Walter S, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Jonkers D, Eswaran S, Chey WD, Kashyap P, Chang L, Mayer EA, Wouters MM, Boeckxstaens G, Camilleri M, Franke A, D'Amato M. Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients. Clin Gastroenterol Hepatol. 2018 Oct;16(10):1673-1676. doi: 10.1016/j.cgh.2018.01.047. Epub 2018 Feb 21. PMID: 29408290; PMCID: PMC6103908.

20 Kim SB, Calmet FH, Garrido J, Garcia-Buitrago MT, Moshiree B. Sucrase-Isomaltase Deficiency as a Potential Masquerader in Irritable Bowel Syndrome. Dig Dis Sci. 2020 Feb;65(2):534-540. doi: 10.1007/s10620-019-05780-7. Epub 2019 Sep 6. PMID: 31493040.

21 Nilholm C, Roth B, Ohlsson B. A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients. Nutrients. 2019 Jul 20;11(7):1662. doi: 10.3390/nu11071662. PMID: 31330810; PMCID: PMC6682926.

22 Craig C. Mitoprotective dietary approaches for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Caloric restriction, fasting, and ketogenic diets. Med Hypotheses. 2015 Nov;85(5):690-3. doi: 10.1016/j.mehy.2015.08.013. Epub 2015 Aug 21. PMID: 26315446.

23 Nakamura S, Hisamura R, Shimoda S, Shibuya I, Tsubota K. Fasting mitigates immediate hypersensitivity: a pivotal role of endogenous D-beta-hydroxybutyrate. Nutr Metab (Lond). 2014 Aug 28;11:40. doi: 10.1186/1743-7075-11-40. PMID: 25302070; PMCID: PMC4190937.

24 Ford RP, Barnes GL. Breath hydrogen test and sucrase isomaltase deficiency. Arch Dis Child. 1983 Aug;58(8):595-7. doi: 10.1136/adc.58.8.595. PMID: 6614973; PMCID: PMC1628322.

25 Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2015 Jul;42(1):3-11. doi: 10.1111/apt.13227. Epub 2015 Apr 27. PMID: 25913530.

26 Westergaard H. Bile Acid malabsorption. Curr Treat Options Gastroenterol. 2007 Feb;10(1):28-33. doi: 10.1007/s11938-007-0054-7. PMID: 17298762.

27 Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007 Feb;3(2):112-22. PMID: 21960820; PMCID: PMC3099351.

28 Sagar NM, Duboc H, Kay GL, Alam MT, Wicaksono AN, Covington JA, Quince C, Kokkorou M, Svolos V, Palmieri LJ, Gerasimidis K, Walters JRF, Arasaradnam RP. The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids. Sci Rep. 2020 Nov 24;10(1):20436. doi: 10.1038/s41598-020-77374-7. PMID: 33235223; PMCID: PMC7686486.

29 Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 2015 May 23;9(3):332-9. doi: 10.5009/gnl14397. PMID: 25918262; PMCID: PMC4413966.

30 Jackson A, Lalji A, Kabir M, Muls A, Gee C, Vyoral S, Shaw C, Andreyev HJN. The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption – outcomes in patients previously treated for cancer. Clin Med (Lond). 2017 Oct;17(5):412-418. doi: 10.7861/clinmedicine.17-5-412. PMID: 28974589; PMCID: PMC6301937.

31 Costa S, Gattoni S, Nicolardi ML, Costetti M, Maimaris S, Schiepatti A, Biagi F. Prevalence and clinical features of bile acid diarrhea in patients with chronic diarrhea. J Dig Dis. 2021 Feb;22(2):108-112. doi: 10.1111/1751-2980.12969. Epub 2021 Feb 3. PMID: 33438795.

32 Sciarretta G, Furno A, Mazzoni M, Malaguti P. Post-cholecystectomy diarrhea: evidence of bile acid malabsorption assessed by SeHCAT test. Am J Gastroenterol. 1992 Dec;87(12):1852-4. PMID: 1449156.

33 Vijayvargiya P, Busciglio I, Burton D, Donato L, Lueke A, Camilleri M. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples. Clin Gastroenterol Hepatol. 2018 Apr;16(4):522-527. doi: 10.1016/j.cgh.2017.06.039. Epub 2017 Jun 27. PMID: 28666948; PMCID: PMC5745308.

34 Eswaran S, Guentner A, Chey WD. Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation. J Neurogastroenterol Motil. 2014 Apr 30;20(2):141-51. doi: 10.5056/jnm.2014.20.2.141. PMID: 24840367; PMCID: PMC4015201.

35 Perbtani Y, Forsmark CE. Update on the diagnosis and management of exocrine pancreatic insufficiency. F1000Res. 2019 Nov 26;8:F1000 Faculty Rev-1991. doi: 10.12688/f1000research.20779.1. PMID: 31824646; PMCID: PMC6880257.

36 Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, Morley S, Sanders DS. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol. 2010 May;8(5):433-8. doi: 10.1016/j.cgh.2009.09.032. Epub 2009 Oct 14. PMID: 19835990.

37 Hart PA, Conwell DL. Diagnosis of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol. 2015 Sep;13(3):347-53. doi: 10.1007/s11938-015-0057-8. PMID: 26077487.

38 Baenkler HW. Salicylate intolerance: pathophysiology, clinical spectrum, diagnosis and treatment. Dtsch Arztebl Int. 2008 Feb;105(8):137-42. doi: 10.3238/arztebl.2008.0137. Epub 2008 Feb 22. PMID: 19633779; PMCID: PMC2696737.

39 Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhaus B, Kimpel S, Koch H, Mach K, Hahn EG, Konturek PC. Significance of salicylate intolerance in diseases of the lower gastrointestinal tract. J Physiol Pharmacol. 2005 Sep;56 Suppl 5:89-102. PMID: 16247191.

40 Tuck CJ, Malakar S, Barrett JS, Muir JG, Gibson PR. Naturally-occurring dietary salicylates in the genesis of functional gastrointestinal symptoms in patients with irritable bowel syndrome: Pilot study. JGH Open. 2021 Jul 21;5(8):871-878. doi: 10.1002/jgh3.12578. PMID: 34386594; PMCID: PMC8341183.

41 Velten FW, Bayerl C, Baenkler HW, Schaefer D. Functional eicosanoid test and typing (FET) in acetylsalicylic acid intolerant patients with urticaria. J Physiol Pharmacol. 2006 Dec;57 Suppl 12:35-46. PMID: 17244953.

42 Hare LG, Woodside JV, Young IS. Dietary salicylates. J Clin Pathol. 2003 Sep;56(9):649-50. doi: 10.1136/jcp.56.9.649. PMID: 12944545; PMCID: PMC1770049.

43 Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, Latorre-Moratalla M, Vidal-Carou MDC. Histamine Intolerance: The Current State of the Art. Biomolecules. 2020 Aug 14;10(8):1181. doi: 10.3390/biom10081181. PMID: 32824107; PMCID: PMC7463562.

44 Wöhrl S, Hemmer W, Focke M, Rappersberger K, Jarisch R. Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine. Allergy Asthma Proc. 2004 Sep-Oct;25(5):305-11. PMID: 15603203.

45 Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007 May;85(5):1185-96. doi: 10.1093/ajcn/85.5.1185. PMID: 17490952.

46 Befani O, Shiozaki TS, Turini P, Gerosa P, Mondovi B. Inhibition of diamine oxidase activity by metronidazole. Biochem Biophys Res Commun. 1995 Jul 17;212(2):589-94. doi: 10.1006/bbrc.1995.2010. PMID: 7626074.

47 Schmidt WU, Sattler J, Hesterberg R, Röher HD, Zoedler T, Sitter H, Lorenz W. Human intestinal diamine oxidase (DAO) activity in Crohn's disease: a new marker for disease assessment? Agents Actions. 1990 Apr;30(1-2):267-70. doi: 10.1007/BF01969057. PMID: 2115243.

48 Rosell-Camps A, Zibetti S, Pérez-Esteban G, Vila-Vidal M, Ferrés-Ramis L, García-Teresa-García E. Histamine intolerance as a cause of chronic digestive complaints in pediatric patients. Rev Esp Enferm Dig. 2013 Apr;105(4):201-6. doi: 10.4321/s1130-01082013000400004. PMID: 23859448.

49 San Mauro Martin I, Brachero S, Garicano Vilar E. Histamine intolerance and dietary management: A complete review. Allergol Immunopathol (Madr). 2016 Sep-Oct;44(5):475-83. doi: 10.1016/j.aller.2016.04.015. Epub 2016 Aug 31. PMID: 27590961.

50 Schnedl WJ, Schenk M, Lackner S, Enko D, Mangge H, Forster F. Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. Food Sci Biotechnol. 2019 May 24;28(6):1779-1784. doi: 10.1007/s10068-019-00627-3. PMID: 31807350; PMCID: PMC6859183.

51 Schnedl WJ, Enko D. Histamine Intolerance Originates in the Gut. Nutrients. 2021 Apr 12;13(4):1262. doi: 10.3390/nu13041262. PMID: 33921522; PMCID: PMC8069563.

52 Schink M, Konturek PC, Tietz E, Dieterich W, Pinzer TC, Wirtz S, Neurath MF, Zopf Y. Microbial patterns in patients with histamine intolerance. J Physiol Pharmacol. 2018 Aug;69(4). doi: 10.26402/jpp.2018.4.09. Epub 2018 Dec 9. PMID: 30552302.

53 Miyoshi M, Ueno M, Matsuo M, Hamada Y, Takahashi M, Yamamoto M, Yamamoto I, Mikajiri R, Tabuchi S, Wakida K, Yamanishi M, Hirai M, Usami M. Effect of dietary fatty acid and micronutrient intake/energy ratio on serum diamine oxidase activity in healthy women. Nutrition. 2017 Jul-Aug;39-40:67-70. doi: 10.1016/j.nut.2017.03.004. Epub 2017 Mar 28. PMID: 28606572.

 

54 Fukudome I, Kobayashi M, Dabanaka K, Maeda H, Okamoto K, Okabayashi T, Baba R, Kumagai N, Oba K, Fujita M, Hanazaki K. Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats. Med Mol Morphol. 2014 Jun;47(2):100-7. doi: 10.1007/s00795-013-0055-7. Epub 2013 Sep 5. PMID: 24005798.

 

1 Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S, Enyati N, Pasia G, Maesincee D, Ocon V, Abdulridha M, Longo VD. Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Rep. 2019 Mar 5;26(10):2704-2719.e6. doi: 10.1016/j.celrep.2019.02.019. PMID: 30840892; PMCID: PMC6528490.

2 Song S, Bai M, Ling Z, Lin Y, Wang S, Chen Y. Intermittent administration of a fasting-mimicking diet reduces intestinal inflammation and promotes repair to ameliorate inflammatory bowel disease in mice. J Nutr Biochem. 2021 Oct;96:108785. doi: 10.1016/j.jnutbio.2021.108785. Epub 2021 Jun 1. PMID: 34087411.

3 Nakamura S, Hisamura R, Shimoda S, Shibuya I, Tsubota K. Fasting mitigates immediate hypersensitivity: a pivotal role of endogenous D-beta-hydroxybutyrate. Nutr Metab (Lond). 2014 Aug 28;11:40. doi: 10.1186/1743-7075-11-40. PMID: 25302070; PMCID: PMC4190937.

4 Kanazawa M, Fukudo S. Effects of fasting therapy on irritable bowel syndrome. Int J Behav Med. 2006;13(3):214-20. doi: 10.1207/s15327558ijbm1303_4. PMID: 17078771.

5 Longo VD, Panda S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metab. 2016 Jun 14;23(6):1048-1059. doi: 10.1016/j.cmet.2016.06.001. PMID: 27304506; PMCID: PMC5388543.

6 Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014 Feb 4;19(2):181-92. doi: 10.1016/j.cmet.2013.12.008. Epub 2014 Jan 16. PMID: 24440038; PMCID: PMC3946160.

7 Johnson JB, John S, Laub DR. Pretreatment with alternate day modified fast will permit higher dose and frequency of cancer chemotherapy and better cure rates. Med Hypotheses. 2009 Apr;72(4):381-2. doi: 10.1016/j.mehy.2008.07.064. Epub 2009 Jan 9. PMID: 19135806.

8 Smith RL, Soeters MR, Wüst RCI, Houtkooper RH. Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease. Endocr Rev. 2018 Aug 1;39(4):489-517. doi: 10.1210/er.2017-00211. PMID: 29697773; PMCID: PMC6093334.

9 Goodpaster BH, Sparks LM. Metabolic Flexibility in Health and Disease. Cell Metab. 2017 May 2;25(5):1027-1036. doi: 10.1016/j.cmet.2017.04.015. PMID: 28467922; PMCID: PMC5513193.

10 Dedual MA, Wueest S, Borsigova M, Konrad D. Intermittent fasting improves metabolic flexibility in short-term high-fat diet-fed mice. Am J Physiol Endocrinol Metab. 2019 Nov 1;317(5):E773-E782. doi: 10.1152/ajpendo.00187.2019. Epub 2019 Sep 10. PMID: 31503513.

11 Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, Da Sacco S, Mirisola M, Quinn DI, Dorff TB, Kopchick JJ, Longo VD. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014 Jun 5;14(6):810-23. doi: 10.1016/j.stem.2014.04.014. Erratum in: Cell Stem Cell. 2016 Feb 4;18(2):291-2. PMID: 24905167; PMCID: PMC4102383.

12 Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti PS, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab. 2015 Jul 7;22(1):86-99. doi: 10.1016/j.cmet.2015.05.012. Epub 2015 Jun 18. PMID: 26094889; PMCID: PMC4509734.

13 Zhang X, Zou Q, Zhao B, Zhang J, Zhao W, Li Y, Liu R, Liu X, Liu Z. Effects of alternate-day fasting, time-restricted fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders. Redox Biol. 2020 May;32:101535. doi: 10.1016/j.redox.2020.101535. Epub 2020 Apr 10. Erratum in: Redox Biol. 2021 Aug;44:101955. PMID: 32305005; PMCID: PMC7162980.

14 Charlot A, Hutt F, Sabatier E, Zoll J. Beneficial Effects of Early Time-Restricted Feeding on Metabolic Diseases: Importance of Aligning Food Habits with the Circadian Clock. Nutrients. 2021 Apr 22;13(5):1405. doi: 10.3390/nu13051405. PMID: 33921979; PMCID: PMC8143522.

15 Lewin R. Man the Scavenger: Hominids of 2 million years ago ate meat: but were they hunters or scavengers? A scavenging hypothesis has now been fully articulated. Science. 1984 May 25;224(4651):861-2. doi: 10.1126/science.224.4651.861. PMID: 17743189.

16 Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S, Suarez J, Michalsen A, Cross AH, Morgan TE, Wei M, Paul F, Bock M, Longo VD. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. Cell Rep. 2016 Jun 7;15(10):2136-2146. doi: 10.1016/j.celrep.2016.05.009. Epub 2016 May 26. PMID: 27239035; PMCID: PMC4899145.

17 Mesnage R, Grundler F, Schwiertz A, Le Maho Y, Wilhelmi de Toledo F. Changes in human gut microbiota composition are linked to the energy metabolic switch during 10 d of Buchinger fasting. J Nutr Sci. 2019 Nov 12;8:e36. doi: 10.1017/jns.2019.33. PMID: 31798864; PMCID: PMC6861737.

18 Sadeghian M, Hosseini SA, Zare Javid A, Ahmadi Angali K, Mashkournia A. Effect of Fasting-Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically Healthy Women with Obesity: a Randomized Controlled, Parallel Trial. Obes Surg. 2021 May;31(5):2030-2039. doi: 10.1007/s11695-020-05202-y. Epub 2021 Jan 9. PMID: 33420673.

19 Wilhelmi de Toledo F, Buchinger A, Burggrabe H, Hölz G, Kuhn C, Lischka E, Lischka N, Lützner H, May W, Ritzmann-Widderich M, Stange R, Wessel A, Boschmann M, Peper E, Michalsen A; Medical Association for Fasting and Nutrition (Ärztegesellschaft für Heilfasten und Ernährung, ÄGHE. Fasting therapy – an expert panel update of the 2002 consensus guidelines. Forsch Komplementmed. 2013;20(6):434-43. doi: 10.1159/000357602. Epub 2013 Dec 16. PMID: 24434758.

20 Rajpal A, Ismail-Beigi F. Intermittent fasting and 'metabolic switch': Effects on metabolic syndrome, prediabetes and type 2 diabetes. Diabetes Obes Metab. 2020 Sep;22(9):1496-1510. doi: 10.1111/dom.14080. Epub 2020 Jun 3. PMID: 32372521.

21 Finnell JS, Saul BC, Goldhamer AC, Myers TR. Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. BMC Complement Altern Med. 2018 Feb 20;18(1):67. doi: 10.1186/s12906-018-2136-6. PMID: 29458369; PMCID: PMC5819235.

22 Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. 2008 Jun 28;336(7659):1495-8. doi: 10.1136/bmj.a301. PMID: 18583681; PMCID: PMC2440847.

 

23 Babic T, Browning KN. The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol. 2014 Jan 5;722:38-47. doi: 10.1016/j.ejphar.2013.08.047. Epub 2013 Oct 31. PMID: 24184670; PMCID: PMC3893663.

 

1 Davis S. Reversal of Irritable Bowel Syndrome, Sleep Disturbance, and Fatigue With an Elimination Diet, Lifestyle Modification, and Dietary Supplements: A Case Report. Integr Med (Encinitas). 2016 Oct;15(5):60-66. PMID: 27980496; PMCID: PMC5145014.

2 Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr. 2006 Dec;25(6):514-22. doi: 10.1080/07315724.2006.10719567. PMID: 17229899.

3 Czeisler CA, Gooley JJ. Sleep and circadian rhythms in humans. Cold Spring Harb Symp Quant Biol. 2007;72:579-97. doi: 10.1101/sqb.2007.72.064. PMID: 18419318.

4 Kowalska E, Brown SA. Peripheral clocks: keeping up with the master clock. Cold Spring Harb Symp Quant Biol. 2007;72:301-5. doi: 10.1101/sqb.2007.72.014. PMID: 18419287.

5 Green A, Cohen-Zion M, Haim A, Dagan Y. Evening light exposure to computer screens disrupts human sleep, biological rhythms, and attention abilities. Chronobiol Int. 2017;34(7):855-865. doi: 10.1080/07420528.2017.1324878. Epub 2017 May 26. PMID: 28548897.

6 Hou Y, Liu L, Chen X, Li Q, Li J. Association between circadian disruption and diseases: A narrative review. Life Sci. 2020 Dec 1;262:118512. doi: 10.1016/j.lfs.2020.118512. Epub 2020 Sep 30. PMID: 33010281.

7 Figueiro MG, White RD. Health consequences of shift work and implications for structural design. J Perinatol. 2013 Apr;33 Suppl 1:S17-23. doi: 10.1038/jp.2013.7. PMID: 23536025.

8 Stothard ER, McHill AW, Depner CM, Birks BR, Moehlman TM, Ritchie HK, Guzzetti JR, Chinoy ED, LeBourgeois MK, Axelsson J, Wright KP Jr. Circadian Entrainment to the Natural Light-Dark Cycle across Seasons and the Weekend. Curr Biol. 2017 Feb 20;27(4):508-513. doi: 10.1016/j.cub.2016.12.041. Epub 2017 Feb 2. PMID: 28162893; PMCID: PMC5335920.

9 Nováková M, Sládek M, Sumová A. Human chronotype is determined in bodily cells under real-life conditions. Chronobiol Int. 2013 May;30(4):607-17. doi: 10.3109/07420528.2012.754455. Epub 2013 Feb 27. PMID: 23445508.

10 Codoñer-Franch P, Gombert M. Circadian rhythms in the pathogenesis of gastrointestinal diseases. World J Gastroenterol. 2018 Oct 14;24(38):4297-4303. doi: 10.3748/wjg.v24.i38.4297. PMID: 30344415; PMCID: PMC6189841.

11 Voigt RM, Forsyth CB, Keshavarzian A. Circadian rhythms: a regulator of gastrointestinal health and dysfunction. Expert Rev Gastroenterol Hepatol. 2019 May;13(5):411-424. doi: 10.1080/17474124.2019.1595588. Epub 2019 Mar 25. PMID: 30874451; PMCID: PMC6533073.

12 Duboc H, Coffin B, Siproudhis L. Disruption of Circadian Rhythms and Gut Motility: An Overview of Underlying Mechanisms and Associated Pathologies. J Clin Gastroenterol. 2020 May/Jun;54(5):405-414. doi: 10.1097/MCG.0000000000001333. PMID: 32134798; PMCID: PMC7147411.

13 Roberts-Thomson IC, Knight RE, Kennaway DJ, Pannall PR. Circadian rhythms in patients with abdominal pain syndromes. Aust N Z J Med. 1988 Jun;18(4):569-74. doi: 10.1111/j.1445-5994.1988.tb00126.x. PMID: 3196244.

14 Matenchuk BA, Mandhane PJ, Kozyrskyj AL. Sleep, circadian rhythm, and gut microbiota. Sleep Med Rev. 2020 Oct;53:101340. doi: 10.1016/j.smrv.2020.101340. Epub 2020 May 13. PMID: 32668369.

15 Tu Q, Heitkemper MM, Jarrett ME, Buchanan DT. Sleep disturbances in irritable bowel syndrome: a systematic review. Neurogastroenterol Motil. 2017 Mar;29(3). doi: 10.1111/nmo.12946. Epub 2016 Sep 28. PMID: 27683238.

16 Chaput JP, McNeil J, Després JP, Bouchard C, Tremblay A. Seven to eight hours of sleep a night is associated with a lower prevalence of the metabolic syndrome and reduced overall cardiometabolic risk in adults. PLoS One. 2013 Sep 5;8(9):e72832. doi: 10.1371/journal.pone.0072832. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/1bf80584-08ec-47c2-ba45-4e77554cd50a. PMID: 24039808; PMCID: PMC3764138.

17 Giménez MC, Hessels M, van de Werken M, de Vries B, Beersma DG, Gordijn MC. Effects of artificial dawn on subjective ratings of sleep inertia and dim light melatonin onset. Chronobiol Int. 2010 Jul;27(6):1219-41. doi: 10.3109/07420528.2010.496912. PMID: 20653451.

18 Thompson A, Jones H, Gregson W, Atkinson G. Effects of dawn simulation on markers of sleep inertia and post-waking performance in humans. Eur J Appl Physiol. 2014 May;114(5):1049-56. doi: 10.1007/s00421-014-2831-z. Epub 2014 Feb 11. PMID: 24509892.

19 Refinetti R. Comparison of light, food, and temperature as environmental synchronizers of the circadian rhythm of activity in mice. J Physiol Sci. 2015 Jul;65(4):359-66. doi: 10.1007/s12576-015-0374-7. Epub 2015 Mar 24. PMID: 25800223.

20 Park SJ, Tokura H. Bright light exposure during the daytime affects circadian rhythms of urinary melatonin and salivary immunoglobulin A. Chronobiol Int. 1999 May;16(3):359-71. doi: 10.3109/07420529909116864. PMID: 10373104.

21 Burgess HJ, Molina TA. Home lighting before usual bedtime impacts circadian timing: a field study. Photochem Photobiol. 2014 May-Jun;90(3):723-6. doi: 10.1111/php.12241. PMID: 24918238; PMCID: PMC4053688.

22 Höhn C, Schmid SR, Plamberger CP, Bothe K, Angerer M, Gruber G, Pletzer B, Hoedlmoser K. Preliminary Results: The Impact of Smartphone Use and Short-Wavelength Light during the Evening on Circadian Rhythm, Sleep and Alertness. Clocks Sleep. 2021 Jan 22;3(1):66-86. doi: 10.3390/clockssleep3010005. PMID: 33499010; PMCID: PMC7838958.

23 Kahn M, Sheppes G, Sadeh A. Sleep and emotions: bidirectional links and underlying mechanisms. Int J Psychophysiol. 2013 Aug;89(2):218-28. doi: 10.1016/j.ijpsycho.2013.05.010. Epub 2013 May 24. PMID: 23711996.

24 Exelmans L, Van den Bulck J. Binge Viewing, Sleep, and the Role of Pre-Sleep Arousal. J Clin Sleep Med. 2017 Aug 15;13(8):1001-1008. doi: 10.5664/jcsm.6704. PMID: 28728618; PMCID: PMC5529125.

25 Nunn CL, Samson DR, Krystal AD. Shining evolutionary light on human sleep and sleep disorders. Evol Med Public Health. 2016 Aug 3;2016(1):227-43. doi: 10.1093/emph/eow018. PMID: 27470330; PMCID: PMC4972941.

26 aan het Rot M, Moskowitz DS, Young SN. Exposure to bright light is associated with positive social interaction and good mood over short time periods: A naturalistic study in mildly seasonal people. J Psychiatr Res. 2008 Mar;42(4):311-9. doi: 10.1016/j.jpsychires.2006.11.010. Epub 2007 Feb 1. PMID: 17275841.

27 Wood AM, Joseph S, Lloyd J, Atkins S. Gratitude influences sleep through the mechanism of pre-sleep cognitions. J Psychosom Res. 2009 Jan;66(1):43-8. doi: 10.1016/j.jpsychores.2008.09.002. Epub 2008 Nov 22. PMID: 19073292.

28 Haghayegh S, Khoshnevis S, Smolensky MH, Diller KR, Castriotta RJ. Before-bedtime passive body heating by warm shower or bath to improve sleep: A systematic review and meta-analysis. Sleep Med Rev. 2019 Aug;46:124-135. doi: 10.1016/j.smrv.2019.04.008. Epub 2019 Apr 19. PMID: 31102877.

29 Lastella M, O'Mullan C, Paterson JL, Reynolds AC. Sex and Sleep: Perceptions of Sex as a Sleep Promoting Behavior in the General Adult Population. Front Public Health. 2019 Mar 4;7:33. doi: 10.3389/fpubh.2019.00033. PMID: 30886838; PMCID: PMC6409294.

30 Yamauchi M, Jacono FJ, Fujita Y, Kumamoto M, Yoshikawa M, Campanaro CK, Loparo KA, Strohl KP, Kimura H. Effects of environment light during sleep on autonomic functions of heart rate and breathing. Sleep Breath. 2014 Dec;18(4):829-35. doi: 10.1007/s11325-014-0951-7. Epub 2014 Feb 13. PMID: 24522288.

31 Cho CH, Yoon HK, Kang SG, Kim L, Lee EI, Lee HJ. Impact of Exposure to Dim Light at Night on Sleep in Female and Comparison with Male Subjects. Psychiatry Investig. 2018 May;15(5):520-530. doi: 10.30773/pi.2018.03.17. Epub 2018 Mar 19. PMID: 29551048; PMCID: PMC5976009.

32 Bani Younis MK, Hayajneh FA, Alduraidi H. Effectiveness of using eye mask and earplugs on sleep length and quality among intensive care patients: A quasi-experimental study. Int J Nurs Pract. 2019 Jun;25(3):e12740. doi: 10.1111/ijn.12740. Epub 2019 May 14. PMID: 31090172.

33 Fang CS, Wang HH, Wang RH, Chou FH, Chang SL, Fang CJ. Effect of earplugs and eye masks on the sleep quality of intensive care unit patients: A systematic review and meta-analysis. J Adv Nurs. 2021 Nov;77(11):4321-4331. doi: 10.1111/jan.14914. Epub 2021 Jun 7. PMID: 34096647.

34 Okamoto-Mizuno K, Mizuno K. Effects of thermal environment on sleep and circadian rhythm. J Physiol Anthropol. 2012 May 31;31(1):14. doi: 10.1186/1880-6805-31-14. PMID: 22738673; PMCID: PMC3427038.

35 Tsuzuki K, Morito N, Nishimiya H. Sleep quality and air conditioner use. Extrem Physiol Med. 2015;4(Suppl 1):A129. Published 2015 Sep 14. doi:10.1186/2046-7648-4-S1-A129.

36 Sadeghian M, Sadeghi O, Hassanzadeh Keshteli A, Daghaghzadeh H, Esmaillzadeh A, Adibi P. Physical activity in relation to irritable bowel syndrome among Iranian adults. PLoS One. 2018 Oct 18;13(10):e0205806. doi: 10.1371/journal.pone.0205806. PMID: 30335859; PMCID: PMC6193664.

37 Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2011 May;106(5):915-22. doi: 10.1038/ajg.2010.480. Epub 2011 Jan 4. PMID: 21206488.

38 Fani M, Mostamand J, Fani M, Chitsaz N, Feizi A. The effect of aerobic exercises among women with mild and moderate irritable bowel syndrome: A pilot study. J Bodyw Mov Ther. 2019 Jan;23(1):161-165. doi: 10.1016/j.jbmt.2018.02.003. Epub 2018 Feb 5. PMID: 30691746.

39 Hamaguchi T, Tayama J, Suzuki M, Nakaya N, Takizawa H, Koizumi K, Amano Y, Kanazawa M, Fukudo S. The effects of locomotor activity on gastrointestinal symptoms of irritable bowel syndrome among younger people: An observational study. PLoS One. 2020 May 29;15(5):e0234089. doi: 10.1371/journal.pone.0234089. Erratum in: PLoS One. 2020 Dec 17;15(12):e0244465. PMID: 32470098; PMCID: PMC7259724.

40 Balmus IM, Ciobica A, Cojocariu R, Luca AC, Gorgan L. Irritable Bowel Syndrome and Neurological Deficiencies: Is There A Relationship? The Possible Relevance of the Oxidative Stress Status. Medicina (Kaunas). 2020 Apr 13;56(4):175. doi: 10.3390/medicina56040175. PMID: 32295083; PMCID: PMC7230401.

41 Hajizadeh Maleki B, Tartibian B, Mooren FC, FitzGerald LZ, Krüger K, Chehrazi M, Malandish A. Low-to-moderate intensity aerobic exercise training modulates irritable bowel syndrome through antioxidative and inflammatory mechanisms in women: Results of a randomized controlled trial. Cytokine. 2018 Feb;102:18-25. doi: 10.1016/j.cyto.2017.12.016. Epub 2017 Dec 21. PMID: 29274540.

42 Keeffe EB, Lowe DK, Goss JR, Wayne R. Gastrointestinal symptoms of marathon runners. West J Med. 1984 Oct;141(4):481-4. PMID: 6506684; PMCID: PMC1021858.

43 Riddoch C, Trinick T. Gastrointestinal disturbances in marathon runners. Br J Sports Med. 1988 Jun;22(2):71-4. doi: 10.1136/bjsm.22.2.71. PMID: 3167507; PMCID: PMC1478552.

44 de Oliveira EP. Runner's diarrhea: what is it, what causes it, and how can it be prevented? Curr Opin Gastroenterol. 2017 Jan;33(1):41-46. doi: 10.1097/MOG.0000000000000322. PMID: 27798441.

45 Lis DM, Stellingwerff T, Kitic CM, Fell JW, Ahuja KDK. Low FODMAP: A Preliminary Strategy to Reduce Gastrointestinal Distress in Athletes. Med Sci Sports Exerc. 2018 Jan;50(1):116-123. doi: 10.1249/MSS.0000000000001419. PMID: 28891824.

46 Sugaya N, Izawa S, Saito K, Shirotsuki K, Nomura S, Shimada H. Effect of prolonged stress on the adrenal hormones of individuals with irritable bowel syndrome. Biopsychosoc Med. 2015 Jan 23;9(1):4. doi: 10.1186/s13030-015-0031-7. PMID: 25632298; PMCID: PMC4308893.

47 Crewther B, Cronin J, Keogh J, Cook C. The salivary testosterone and cortisol response to three loading schemes. J Strength Cond Res. 2008 Jan;22(1):250-5. doi: 10.1519/JSC.0b013e31815f5f91. PMID: 18296983.

48 Mangine GT, Hoffman JR, Gonzalez AM, Townsend JR, Wells AJ, Jajtner AR, Beyer KS, Boone CH, Miramonti AA, Wang R, LaMonica MB, Fukuda DH, Ratamess NA, Stout JR. The effect of training volume and intensity on improvements in muscular strength and size in resistance-trained men. Physiol Rep. 2015 Aug;3(8):e12472. doi: 10.14814/phy2.12472. PMID: 26272733; PMCID: PMC4562558.

49 Kindlon T. Do graded activity therapies cause harm in chronic fatigue syndrome? J Health Psychol. 2017 Aug;22(9):1146-1154. doi: 10.1177/1359105317697323. Epub 2017 Mar 20. PMID: 28805516.

50 Maes M, Coucke F, Leunis JC. Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro Endocrinol Lett. 2007 Dec;28(6):739-44. PMID: 18063928.

51 Zhou C, Zhao E, Li Y, Jia Y, Li F. Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials. Neurogastroenterol Motil. 2019 Feb;31(2):e13461. doi: 10.1111/nmo.13461. Epub 2018 Sep 19. PMID: 30232834.

52 Kavuri V, Raghuram N, Malamud A, Selvan SR. Irritable Bowel Syndrome: Yoga as Remedial Therapy. Evid Based Complement Alternat Med. 2015;2015:398156. doi: 10.1155/2015/398156. Epub 2015 May 6. PMID: 26064164; PMCID: PMC4438173.

53 D'Silva A, MacQueen G, Nasser Y, Taylor LM, Vallance JK, Raman M. Yoga as a Therapy for Irritable Bowel Syndrome. Dig Dis Sci. 2020 Sep;65(9):2503-2514. doi: 10.1007/s10620-019-05989-6. Epub 2019 Dec 12. PMID: 31832970.

54 Taneja I, Deepak KK, Poojary G, Acharya IN, Pandey RM, Sharma MP. Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study. Appl Psychophysiol Biofeedback. 2004 Mar;29(1):19-33. doi: 10.1023/b:apbi.0000017861.60439.95. PMID: 15077462.

55 Russo MA, Santarelli DM, O'Rourke D. The physiological effects of slow breathing in the healthy human. Breathe (Sheff). 2017 Dec;13(4):298-309. doi: 10.1183/20734735.009817. PMID: 29209423; PMCID: PMC5709795.

56 Telles S, Nagarathna R, Nagendra HR. Breathing through a particular nostril can alter metabolism and autonomic activities. Indian J Physiol Pharmacol. 1994 Apr;38(2):133-7. PMID: 8063359.

57 Telles S, Nagarathna R, Nagendra HR. Physiological measures of right nostril breathing. J Altern Complement Med. 1996 Winter;2(4):479-84. doi: 10.1089/acm.1996.2.479. PMID: 9395677.

58 Enck P, Junne F, Klosterhalfen S, Zipfel S, Martens U. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1402-11. doi: 10.1097/MEG.0b013e3283405a17. PMID: 21389791.

59 Yadav SK, Jain AK, Bahre PB, Gupta JP. Neuroticism in patients with irritable bowel syndrome. Indian J Gastroenterol. 1990 Jan;9(1):29-31. PMID: 2307499.

60 Sirois FM, Molnar DS. Perfectionism and maladaptive coping styles in patients with chronic fatigue syndrome, irritable bowel syndrome and fibromyalgia/arthritis and in healthy controls. Psychother Psychosom. 2014;83(6):384-5. doi: 10.1159/000365174. Epub 2014 Oct 16. PMID: 25323951.

61 Shiha MG, Aziz I. Review article: Physical and psychological comorbidities associated with irritable bowel syndrome. Aliment Pharmacol Ther. 2021 Dec;54 Suppl 1:S12-S23. doi: 10.1111/apt.16589. PMID: 34927759.

62 Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther. 2003 Jan-Feb;10(1):61-7. doi: 10.1097/00045391-200301000-00014. PMID: 12522523.

63 Bradford K, Shih W, Videlock EJ, Presson AP, Naliboff BD, Mayer EA, Chang L. Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol. 2012 Apr;10(4):385-90.e1-3. doi: 10.1016/j.cgh.2011.12.018. Epub 2011 Dec 16. PMID: 22178460; PMCID: PMC3311761.

64 Hislop IG. Effect of very brief psychotherapy on the irritable bowel syndrome. Med J Aust. 1980 Nov 29;2(11):620-3. doi: 10.5694/j.1326-5377.1980.tb77066.x. PMID: 7464621.

65 Lancaster-Smith MJ, Prout BJ, Pinto T, Anderson JA, Schiff AA. Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand. 1982 Jul;66(1):33-41. doi: 10.1111/j.1600-0447.1982.tb00912.x. PMID: 7124431.

66 Eijsbouts C, Zheng T, Kennedy NA, Bonfiglio F, Anderson CA, Moutsianas L, Holliday J, Shi J, Shringarpure S; 23andMe Research Team, Voda AI; Bellygenes Initiative, Farrugia G, Franke A, Hübenthal M, Abecasis G, Zawistowski M, Skogholt AH, Ness-Jensen E, Hveem K, Esko T, Teder-Laving M, Zhernakova A, Camilleri M, Boeckxstaens G, Whorwell PJ, Spiller R, McVean G, D'Amato M, Jostins L, Parkes M. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Nat Genet. 2021 Nov;53(11):1543-1552. doi: 10.1038/s41588-021-00950-8. Epub 2021 Nov 5. PMID: 34741163; PMCID: PMC8571093.

67 Enck P, Martens U, Klosterhalfen S. The psyche and the gut. World J Gastroenterol. 2007 Jul 7;13(25):3405-8. doi: 10.3748/wjg.v13.i25.3405. PMID: 17659685; PMCID: PMC4146774.

68 Kilinçarslan S, Evrensel A. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with inflammatory bowel disease: an experimental study. Actas Esp Psiquiatr. 2020 Jan;48(1):1-7. Epub 2020 Jan 1. PMID: 32297646.

69 Househam AM, Peterson CT, Mills PJ, Chopra D. The Effects of Stress and Meditation on the Immune System, Human Microbiota, and Epigenetics. Adv Mind Body Med. 2017 Fall;31(4):10-25. PMID: 29306937.

70 Hantsoo L, Zemel BS. Stress gets into the belly: Early life stress and the gut microbiome. Behav Brain Res. 2021 Sep 24;414:113474. doi: 10.1016/j.bbr.2021.113474. Epub 2021 Jul 16. PMID: 34280457; PMCID: PMC8380711.

71 Xie P, Kranzler HR, Yang C, Zhao H, Farrer LA, Gelernter J. Genome-wide association study identifies new susceptibility loci for posttraumatic stress disorder. Biol Psychiatry. 2013 Nov 1;74(9):656-63. doi: 10.1016/j.biopsych.2013.04.013. Epub 2013 May 28. PMID: 23726511; PMCID: PMC3810148.

72 Andresen V, Löwe B, Broicher W, Riegel B, Fraedrich K, von Wulffen M, Gappmayer K, Wegscheider K, Treszl A, Rose M, Layer P, Lohse AW. Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up. United European Gastroenterol J. 2016 Feb;4(1):121-31. doi: 10.1177/2050640615581113. Epub 2015 Apr 28. PMID: 26966532; PMCID: PMC4766540.

73 Barbara G, Grover M, Bercik P, Corsetti M, Ghoshal UC, Ohman L, Rajilić-Stojanović M. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology. 2019 Jan;156(1):46-58.e7. doi: 10.1053/j.gastro.2018.07.011. Epub 2018 Nov 28. PMID: 30009817; PMCID: PMC6309514.

74 Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002 Sep;51(3):410-3. doi: 10.1136/gut.51.3.410. PMID: 12171965; PMCID: PMC1773359.

75 Fava GA, Sonino N. Psychosomatic medicine. Int J Clin Pract. 2010 Jul;64(8):1155-61. doi: 10.1111/j.1742-1241.2009.02266.x. PMID: 20642714.

76 Taft TH, Riehl ME, Dowjotas KL, Keefer L. Moving beyond perceptions: internalized stigma in the irritable bowel syndrome. Neurogastroenterol Motil. 2014 Jul;26(7):1026-35. doi: 10.1111/nmo.12357. Epub 2014 May 16. PMID: 24832499; PMCID: PMC8569739.

77 Björkman I, Jakobsson Ung E, Ringström G, Törnblom H, Simrén M. More similarities than differences between men and women with irritable bowel syndrome. Neurogastroenterol Motil. 2015 Jun;27(6):796-804. doi: 10.1111/nmo.12551. Epub 2015 Mar 26. PMID: 25817301.

78 Kovács Z, Kovács F. [Depressive and anxiety symptoms, coping strategies in patients with irritable bowel syndrome and inflammatory bowel disease]. Psychiatr Hung. 2007;22(3):212-21. Hungarian. PMID: 18167418.

79 Stanculete MF, Matu S, Pojoga C, Dumitrascu DL. Coping strategies and irrational beliefs as mediators of the health-related quality of life impairments in irritable bowel syndrome. J Gastrointestin Liver Dis. 2015 Jun;24(2):159-64. doi: 10.15403/jgld.2014.1121.242.strt. PMID: 26114174.

80 Hofmann SG, Hay AC. Rethinking avoidance: Toward a balanced approach to avoidance in treating anxiety disorders. J Anxiety Disord. 2018 Apr;55:14-21. doi: 10.1016/j.janxdis.2018.03.004. Epub 2018 Mar 9. PMID: 29550689; PMCID: PMC5879019.

81 Sherwin LB, Leary E, Henderson WA. The association of catastrophizing with quality-of-life outcomes in patients with irritable bowel syndrome. Qual Life Res. 2017 Aug;26(8):2161-2170. doi: 10.1007/s11136-017-1554-0. Epub 2017 Mar 21. PMID: 28324323; PMCID: PMC5509838.

82 David L, Fadgyas Stanculete M, Bolba AR, Chiaroni G, Barsan M, Popa SL. Coping Strategies and Irritable Bowel Syndrome: A Systematic Review. J Gastrointestin Liver Dis. 2021 Nov 8. doi: 10.15403/jgld-3937. Epub ahead of print. PMID: 34752585.

83 Torkzadeh F, Danesh M, Mirbagher L, Daghaghzadeh H, Emami MH. Relations between Coping Skills, Symptom Severity, Psychological Symptoms, and Quality of Life in Patients with Irritable Bowel Syndrome. Int J Prev Med. 2019 May 17;10:72. doi: 10.4103/ijpvm.IJPVM_464_17. PMID: 31198507; PMCID: PMC6547787.

84 Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565-90. doi: 10.1146/annurev.psych.59.113006.095941. PMID: 17550344.

85 Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015 Jul;16(7):403-18. doi: 10.1038/nrn3976. PMID: 26087681; PMCID: PMC6013051.

86 Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014 Oct 21;20(39):14126-31. doi: 10.3748/wjg.v20.i39.14126. PMID: 25339801; PMCID: PMC4202343.

87 Roohafza H, Bidaki EZ, Hasanzadeh-Keshteli A, Daghaghzade H, Afshar H, Adibi P. Anxiety, depression and distress among irritable bowel syndrome and their subtypes: An epidemiological population based study. Adv Biomed Res. 2016 Nov 28;5:183. doi: 10.4103/2277-9175.190938. PMID: 28028523; PMCID: PMC5156966.

88 Santos J, Yang PC, Söderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut. 2001 May;48(5):630-6. doi: 10.1136/gut.48.5.630. PMID: 11302959; PMCID: PMC1728291.

89 Naliboff BD, Smith SR, Serpa JG, Laird KT, Stains J, Connolly LS, Labus JS, Tillisch K. Mindfulness-based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness. Neurogastroenterol Motil. 2020 Sep;32(9):e13828. doi: 10.1111/nmo.13828. Epub 2020 Apr 7. PMID: 32266762.

90 Blanchard EB, Greene B, Scharff L, Schwarz-McMorris SP. Relaxation training as a treatment for irritable bowel syndrome. Biofeedback Self Regul. 1993 Sep;18(3):125-32. doi: 10.1007/BF00999789. PMID: 8218507.

91 Shinozaki M, Kanazawa M, Kano M, Endo Y, Nakaya N, Hongo M, Fukudo S. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2010 Sep;35(3):189-98. doi: 10.1007/s10484-009-9125-y. PMID: 19997775.

92 Taylor DA, Genkov KA. Hypnotherapy for the Treatment of Persistent Pain: A Literature Review. J Am Psychiatr Nurses Assoc. 2020 Mar/Apr;26(2):157-161. doi: 10.1177/1078390319835604. Epub 2019 Mar 13. PMID: 30866709.

93 Jensen MP, Adachi T, Tomé-Pires C, Lee J, Osman ZJ, Miró J. Mechanisms of hypnosis: toward the development of a biopsychosocial model. Int J Clin Exp Hypn. 2015;63(1):34-75. doi: 10.1080/00207144.2014.961875. Erratum in: Int J Clin Exp Hypn. 2015;63(2):247. PMID: 25365127; PMCID: PMC4220267.

94 Häuser W, Hagl M, Schmierer A, Hansen E. The Efficacy, Safety and Applications of Medical Hypnosis. Dtsch Arztebl Int. 2016 Apr 29;113(17):289-96. doi: 10.3238/arztebl.2016.0289. PMID: 27173407; PMCID: PMC4873672.

95 Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut. 1987 Apr;28(4):423-5. doi: 10.1136/gut.28.4.423. PMID: 3583070; PMCID: PMC1432815.

96 Gonsalkorale WM. Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome. Int J Clin Exp Hypn. 2006 Jan;54(1):27-50. doi: 10.1080/00207140500323030. PMID: 16316882.

97 Gonsalkorale WM. Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome. Int J Clin Exp Hypn. 2006 Jan;54(1):27-50. doi: 10.1080/00207140500323030. PMID: 16316882.

98 Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2016 Sep;44(5):447-59. doi: 10.1111/apt.13706. Epub 2016 Jul 11. PMID: 27397586.

99 Rutten JMTM, Vlieger AM, Frankenhuis C, George EK, Groeneweg M, Norbruis OF, Tjon A Ten W, van Wering HM, Dijkgraaf MGW, Merkus MP, Benninga MA. Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2017 May 1;171(5):470-477. doi: 10.1001/jamapediatrics.2017.0091. PMID: 28346581.

100 Palsson OS, Turner MJ, Whitehead WE. Hypnosis home treatment for irritable bowel syndrome: a pilot study. Int J Clin Exp Hypn. 2006 Jan;54(1):85-99. doi: 10.1080/00207140500328666. PMID: 16316885.

101 Stanculete MF, Matu S, Pojoga C, Dumitrascu DL. Coping strategies and irrational beliefs as mediators of the health-related quality of life impairments in irritable bowel syndrome. J Gastrointestin Liver Dis. 2015 Jun;24(2):159-64. doi: 10.15403/jgld.2014.1121.242.strt. PMID: 26114174.

102 Muscatello MR, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol. 2014 Jun 28;20(24):7570-86. doi: 10.3748/wjg.v20.i24.7570. PMID: 24976697; PMCID: PMC4069288.

103 Blankstein U, Chen J, Diamant NE, Davis KD. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology. 2010 May;138(5):1783-9. doi: 10.1053/j.gastro.2009.12.043. Epub 2010 Jan 4. PMID: 20045701.

104 Claassen J, Labrenz F, Ernst TM, Icenhour A, Langhorst J, Forsting M, Timmann D, Elsenbruch S. Altered Cerebellar Activity in Visceral Pain-Related Fear Conditioning in Irritable Bowel Syndrome. Cerebellum. 2017 Apr;16(2):508-517. doi: 10.1007/s12311-016-0832-7. PMID: 27797090.

105 Li L, Xiong L, Zhang S, Yu Q, Chen M. Cognitive-behavioral therapy for irritable bowel syndrome: a meta-analysis. J Psychosom Res. 2014 Jul;77(1):1-12. doi: 10.1016/j.jpsychores.2014.03.006. Epub 2014 Mar 26. PMID: 24913335.

106 Hunt M, Miguez S, Dukas B, Onwude O, White S. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021 May 20;9(5):e26152. doi: 10.2196/26152. PMID: 33872182; PMCID: PMC8176342.

 

107 Schulz E, Stankewitz A, Witkovský V, Winkler AM, Tracey I. Strategy-dependent modulation of cortical pain circuits for the attenuation of pain. Cortex. 2019 Apr;113:255-266. doi: 10.1016/j.cortex.2018.12.014. Epub 2019 Jan 4. PMID: 30711854.

 

1 Lewis JH. Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective. Expert Rev Gastroenterol Hepatol. 2010 Feb;4(1):13-29. doi: 10.1586/egh.09.72. PMID: 20136586.

2 Dimidi E, Whelan K. Food supplements and diet as treatment options in irritable bowel syndrome. Neurogastroenterol Motil. 2020 Aug;32(8):e13951. doi: 10.1111/nmo.13951. PMID: 32697018.

3 Asha MZ, Khalil SFH. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis. Sultan Qaboos Univ Med J. 2020 Feb;20(1):e13-e24. doi: 10.18295/squmj.2020.20.01.003. Epub 2020 Mar 9. PMID: 32190365; PMCID: PMC7065695.

4 Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012;61(2):160-74. doi: 10.1159/000342079. Epub 2012 Oct 2. PMID: 23037511.

5 de Simone C. The Unregulated Probiotic Market. Clin Gastroenterol Hepatol. 2019 Apr;17(5):809-817. doi: 10.1016/j.cgh.2018.01.018. Epub 2018 Mar 14. PMID: 29378309.

6 Rao SSC, Rehman A, Yu S, Andino NM. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol. 2018 Jun 19;9(6):162. doi: 10.1038/s41424-018-0030-7. PMID: 29915215; PMCID: PMC6006167.

7 Hrubisko M, Danis R, Huorka M, Wawruch M. Histamine Intolerance-The More We Know the Less We Know. A Review. Nutrients. 2021 Jun 29;13(7):2228. doi: 10.3390/nu13072228. PMID: 34209583; PMCID: PMC8308327.

8 Sisson G, Ayis S, Sherwood RA, Bjarnason I. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. Aliment Pharmacol Ther. 2014 Jul;40(1):51-62. doi: 10.1111/apt.12787. Epub 2014 May 11. PMID: 24815298.

9 Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol. 2016 Dec 28;22(48):10631-10642. doi: 10.3748/wjg.v22.i48.10631. PMID: 28082816; PMCID: PMC5192275.

10 Camilleri M. Management Options for Irritable Bowel Syndrome. Mayo Clin Proc. 2018 Dec;93(12):1858-1872. doi: 10.1016/j.mayocp.2018.04.032. PMID: 30522596; PMCID: PMC6314474.

11 Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kanarek E, Sowińska A, Cukrowska B. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study. Nutrients. 2021 Feb 26;13(3):756. doi: 10.3390/nu13030756. PMID: 33652763; PMCID: PMC7996889.

12 Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1. PMID: 22157240.

13 Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, Shinohara RT, Mullin GE. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med. 2019 Jan 17;19(1):21. doi: 10.1186/s12906-018-2409-0. PMID: 30654773; PMCID: PMC6337770.

14 Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018 Mar;47(6):738-752. doi: 10.1111/apt.14519. Epub 2018 Jan 26. PMID: 29372567; PMCID: PMC5814329.

15 Salaritabar A, Darvishi B, Hadjiakhoondi F, Manayi A, Sureda A, Nabavi SF, Fitzpatrick LR, Nabavi SM, Bishayee A. Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review. World J Gastroenterol. 2017 Jul 28;23(28):5097-5114. doi: 10.3748/wjg.v23.i28.5097. PMID: 28811706; PMCID: PMC5537178.

16 Qin HY, Zang KH, Zuo X, Wu XA, Bian ZX. Quercetin Attenuates Visceral Hypersensitivity and 5-Hydroxytryptamine Availability in Postinflammatory Irritable Bowel Syndrome Rats: Role of Enterochromaffin Cells in the Colon. J Med Food. 2019 Jul;22(7):663-671. doi: 10.1089/jmf.2018.4264. Epub 2019 Mar 28. PMID: 30920336.

17 Jia H, Zhang Y, Si X, Jin Y, Jiang D, Dai Z, Wu Z. Quercetin Alleviates Oxidative Damage by Activating Nuclear Factor Erythroid 2-Related Factor 2 Signaling in Porcine Enterocytes. Nutrients. 2021 Jan 26;13(2):375. doi: 10.3390/nu13020375. PMID: 33530513; PMCID: PMC7911945.

18 Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A, Fu X, Katsarou-Katsari A, Antoniou C, Theoharides TC. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One. 2012;7(3):e33805. doi: 10.1371/journal.pone.0033805. Epub 2012 Mar 28. PMID: 22470478; PMCID: PMC3314669.

19 Roudsari NM, Lashgari NA, Momtaz S, Farzaei MH, Marques AM, Abdolghaffari AH. Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review. Daru. 2019 Dec;27(2):755-780. doi: 10.1007/s40199-019-00284-1. Epub 2019 Jul 4. PMID: 31273572; PMCID: PMC6895345.

20 Stromsnes K, Mas-Bargues C, Gambini J, Gimeno-Mallench L. Protective Effects of Polyphenols Present in Mediterranean Diet on Endothelial Dysfunction. Oxid Med Cell Longev. 2020 Aug 6;2020:2097096. doi: 10.1155/2020/2097096. PMID: 32831990; PMCID: PMC7428938.

21 Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, Altaf N, Zahid M, Ujjan ID, Nigar R, Khushk MI, Phulpoto M, Lail A, Devrajani BR, Ahmed S. Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. Int J Gen Med. 2021 Jun 8;14:2359-2366. doi: 10.2147/IJGM.S318720. PMID: 34135619; PMCID: PMC8197660.

22 Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017 Oct 22;6(10):92. doi: 10.3390/foods6100092. PMID: 29065496; PMCID: PMC5664031.

23 Atefi M, Darand M, Entezari MH, Jamialahmadi T, Bagherniya M, Sahebkar A. A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases. Adv Exp Med Biol. 2021;1291:295-326. doi: 10.1007/978-3-030-56153-6_18. PMID: 34331698.

24 Bundy R, Walker AF, Middleton RW, Booth J. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med. 2004 Dec;10(6):1015-8. doi: 10.1089/acm.2004.10.1015. PMID: 15673996.

25 Brenner DM, Sayuk GS, Gutman CR, Jo E, Elmes SJR, Liu LWC, Cash BD. Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study. Am J Gastroenterol. 2019 Sep;114(9):1502-1511. doi: 10.14309/ajg.0000000000000327. PMID: 31356229; PMCID: PMC6738625.

26 Brenner DM, Sayuk GS, Abel JL, Burslem K. Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide. J Manag Care Spec Pharm. 2021 Apr;27(4):469-477. PMID: 33769858.

27 Lobo B, Ramos L, Martínez C, Guilarte M, González-Castro AM, Alonso-Cotoner C, Pigrau M, de Torres I, Rodiño-Janeiro BK, Salvo-Romero E, Fortea M, Pardo-Camacho C, Guagnozzi D, Azpiroz F, Santos J, Vicario M. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study. United European Gastroenterol J. 2017 Oct;5(6):887-897. doi: 10.1177/2050640617691690. Epub 2017 Jan 29. PMID: 29026603; PMCID: PMC5625876.

28 Wang J, Wang Y, Zhou H, Gu W, Wang X, Yang J. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur J Gastroenterol Hepatol. 2020 Jun;32(6):706-712. doi: 10.1097/MEG.0000000000001737. PMID: 32317585.

29 Lewis JH. Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective. Expert Rev Gastroenterol Hepatol. 2010 Feb;4(1):13-29. doi: 10.1586/egh.09.72. PMID: 20136586.

30 Lembo AJ, Olden KW, Ameen VZ, Gordon SL, Heath AT, Carter EG. Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials. Clin Gastroenterol Hepatol. 2004 Aug;2(8):675-82. doi: 10.1016/s1542-3565(04)00284-8. PMID: 15290660.

31 Qi Q, Zhang Y, Chen F, Zuo X, Li Y. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol. 2018 Jan 8;18(1):5. doi: 10.1186/s12876-017-0734-2. PMID: 29310568; PMCID: PMC5759234.

32 Chiba T, Yamamoto K, Sato S, Suzuki K. Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol. 2013 Jul 25;6:123-8. doi: 10.2147/CEG.S32721. PMID: 23922505; PMCID: PMC3728153.

33 Garsed K, Chernova J, Hastings M, Lam C, Marciani L, Singh G, Henry A, Hall I, Whorwell P, Spiller R. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014 Oct;63(10):1617-25. doi: 10.1136/gutjnl-2013-305989. Epub 2013 Dec 12. PMID: 24334242; PMCID: PMC4173656.

34 Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409. PMID: 21208106.

35 Chey WD, Shah ED, DuPont HL. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therap Adv Gastroenterol. 2020 Jan 23;13:1756284819897531. doi: 10.1177/1756284819897531. PMID: 32047534; PMCID: PMC6984424.

36 Cash BD, Pimentel M, Rao SSC, Weinstock L, Chang L, Heimanson Z, Lembo A. Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial. Therap Adv Gastroenterol. 2017 Sep;10(9):689-699. doi: 10.1177/1756283X17726087. Epub 2017 Sep 11. PMID: 28932270; PMCID: PMC5598815.

37 Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, Paterson C, Bortey E, Forbes WP. Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology. 2016 Dec;151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13. PMID: 27528177.

38 Munjal A, Dedania B, Cash B. Update on Pharmacotherapy for Irritable Bowel Syndrome. Curr Gastroenterol Rep. 2019 Apr 25;21(6):25. doi: 10.1007/s11894-019-0692-7. PMID: 31025114.

39 Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 2020 Jan;69(1):74-82. doi: 10.1136/gutjnl-2018-318160. Epub 2019 Apr 17. PMID: 30996042.

40 Jadallah KA, Kullab SM, Sanders DS. Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies. World J Gastroenterol. 2014 Jul 21;20(27):8898-909. doi: 10.3748/wjg.v20.i27.8898. PMID: 25083062; PMCID: PMC4112860.

41 Wilson N, Schey R. Lubiprostone in constipation: clinical evidence and place in therapy. Ther Adv Chronic Dis. 2015 Mar;6(2):40-50. doi: 10.1177/2040622314567678. PMID: 25729555; PMCID: PMC4331234.

42 Li F, Fu T, Tong WD, Liu BH, Li CX, Gao Y, Wu JS, Wang XF, Zhang AP. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Metaanalysis of Randomized Controlled Trials. Mayo Clin Proc. 2016 Apr;91(4):456-68. doi: 10.1016/j.mayocp.2016.01.015. PMID: 27046523.

43 Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, MacDougall JE, Jia XD, Shao JZ, Fitch DA, Baird MJ, Schneier HA, Johnston JM. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012 Nov;107(11):1702-12. doi: 10.1038/ajg.2012.254. PMID: 22986437.

44 Brenner DM, Fogel R, Dorn SD, Krause R, Eng P, Kirshoff R, Nguyen A, Crozier RA, Magnus L, Griffin PH. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. Am J Gastroenterol. 2018 May;113(5):735-745. doi: 10.1038/s41395-018-0026-7. Epub 2018 Mar 15. PMID: 29545635.

45 Cuppoletti J, Blikslager AT, Chakrabarti J, Nighot PK, Malinowska DH. Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors. BMC Pharmacol. 2012 May 3;12:3. doi: 10.1186/1471-2210-12-3. PMID: 22553939; PMCID: PMC3403872.

46 Chey WD, Lembo AJ, Rosenbaum DP. Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1). Am J Gastroenterol. 2020 Feb;115(2):281-293. doi: 10.14309/ajg.0000000000000516. PMID: 31934897; PMCID: PMC7771640.

47 Stripling J, Rodriguez M. Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases-Clostridium difficile Disease and Beyond. Am J Med Sci. 2018 Nov;356(5):424-432. doi: 10.1016/j.amjms.2018.08.010. Epub 2018 Sep 5. PMID: 30384951.

48 Rose C, Parker A, Jefferson B, Cartmell E. The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology. Crit Rev Environ Sci Technol. 2015 Sep 2;45(17):1827-1879. doi: 10.1080/10643389.2014.1000761. PMID: 26246784; PMCID: PMC4500995.

49 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol. 2021 Nov 4. doi: 10.1111/jgh.15731. Epub ahead of print. PMID: 34735024.

50 Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, Hyland L, Morgan A, Maysey J, Moore-Jones D. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust. 1989 May 15;150(10):604. doi: 10.5694/j.1326-5377.1989.tb136704.x. PMID: 2783214.

51 Halkjær SI, Boolsen AW, Günther S, Christensen AH, Petersen AM. Can fecal microbiota transplantation cure irritable bowel syndrome? World J Gastroenterol. 2017 Jun 14;23(22):4112-4120. doi: 10.3748/wjg.v23.i22.4112. PMID: 28652664; PMCID: PMC5473130.

52 Li N, Tian HL, Chen QY, Yang B, Ma CL, Lin ZL, Zhang XY, Zhao D, Huang ZX, Jiang J, Qin HL. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders]. Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Sep 25;22(9):861-868. Chinese. doi: 10.3760/cma.j.issn.1671-0274.2019.09.011. PMID: 31550826.

53 Singh P, Alm EJ, Kelley JM, Cheng V, Smith M, Kassam Z, Nee J, Iturrino J, Lembo A. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes. 2022 Jan-Dec;14(1):2020067. doi: 10.1080/19490976.2021.2020067. PMID: 35014601; PMCID: PMC8757476.

 

54 El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020 May;69(5):859-867. doi: 10.1136/gutjnl-2019-319630. Epub 2019 Dec 18. PMID: 31852769; PMCID: PMC7229896.

 

1 Walter SA, Kjellström L, Nyhlin H, Talley NJ, Agréus L. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010 May;45(5):556-66. doi: 10.3109/00365520903551332. PMID: 20205503.

2 Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992 Jun;33(6):818-24. doi: 10.1136/gut.33.6.818. PMID: 1624166; PMCID: PMC1379343.

3 Tomlin J, Lowis C, Read NW. Investigation of normal flatus production in healthy volunteers. Gut. 1991 Jun;32(6):665-9. doi: 10.1136/gut.32.6.665. PMID: 1648028; PMCID: PMC1378885.

4 Furne JK, Levitt MD. Factors influencing frequency of flatus emission by healthy subjects. Dig Dis Sci. 1996 Aug;41(8):1631-5. doi: 10.1007/BF02087912. PMID: 8769291.

 

5 Kumbhare SV, Francis-Lyon PA, Kachru D, Uday T, Irudayanathan C, Muthukumar KM, Ricchetti RR, Singh-Rambiritch S, Ugalde J, Dulai PS, Almonacid DE, Sinha R. Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study. Front Microbiol. 2022 Mar 21;13:826916. doi: 10.3389/fmicb.2022.826916. PMID: 35391720; PMCID: PMC8983270.